| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 1.16e-06 | 3 | 211 | 3 | GO:0008332 | |
| GeneOntologyMolecularFunction | histone binding | RSF1 NAP1L2 CHD4 TAF1 HDGFL2 IPO7 CHD7 TSPY26P PWP1 SMARCC1 PHF14 KDM4A | 2.66e-05 | 265 | 211 | 12 | GO:0042393 |
| GeneOntologyMolecularFunction | spectrin binding | 2.72e-05 | 34 | 211 | 5 | GO:0030507 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.09e-04 | 24 | 211 | 4 | GO:0008093 | |
| GeneOntologyMolecularFunction | chromatin binding | TPR HMGN5 NCOA3 ZNF609 AKAP8 NAP1L2 CHD4 TTF1 HDGFL3 SAFB TAF1 RAD21 CHD7 TSPY26P REST IKZF5 NCOR2 MLH3 SMARCC1 KAT6B | 1.18e-04 | 739 | 211 | 20 | GO:0003682 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TPR NCOA3 PAG1 MYH9 MAP1A CHD4 EPB41L3 BCOR BICD1 HTATSF1 HDGFL2 THRAP3 FKBP4 MYBBP1A GTF2A1L ICE1 AKAP12 ZFPM2 NCOR2 CD3E GAS2L2 SMARCC1 PHF14 SCRIB KAT6B HDGF | 2.40e-04 | 1160 | 211 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | protein kinase A binding | 3.65e-04 | 58 | 211 | 5 | GO:0051018 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.89e-04 | 14 | 211 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.28e-04 | 60 | 211 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.48e-04 | 129 | 211 | 7 | GO:0005262 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.60e-04 | 93 | 211 | 6 | GO:0097110 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TPR NCOA3 PAG1 MYH9 MAP1A CHD4 EPB41L3 BCOR BICD1 HTATSF1 PLCB3 HDGFL2 THRAP3 FKBP4 MYBBP1A GTF2A1L ICE1 AKAP12 ZFPM2 NCOR2 CD3E GAS2L2 EIF4G1 SMARCC1 PHF14 SCRIB KAT6B HDGF | 5.14e-04 | 1356 | 211 | 28 | GO:0060090 |
| GeneOntologyMolecularFunction | neurexin family protein binding | 5.88e-04 | 16 | 211 | 3 | GO:0042043 | |
| GeneOntologyMolecularFunction | actin binding | MYO1G MYH9 MAP1A GBP1 GBP2 CLASP2 EPB41L3 DST MYO18A ARPC5 GAS2L2 PPP1R18 EPB41 HDGF | 6.01e-04 | 479 | 211 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO1G TPR MYH9 MAP1A GBP1 GBP2 CLASP2 EPB41L3 DYSF HDGFL3 BICD1 NEFM DST MTCL1 FKBP4 DYNC1I1 KIF16B MYO18A USH1C ARPC5 GAS2L2 PPP1R18 EPB41 HDGF | 6.10e-04 | 1099 | 211 | 24 | GO:0008092 |
| GeneOntologyMolecularFunction | G-protein activated inward rectifier potassium channel activity | 6.58e-04 | 4 | 211 | 2 | GO:0015467 | |
| GeneOntologyMolecularFunction | H3K27me3 modified histone binding | 1.09e-03 | 5 | 211 | 2 | GO:0061628 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | RYR2 KCNJ5 KCNJ9 TRPV2 CACNA1I CACNA1H CACNA1G CNGA2 PIEZO2 CNGB3 SLC24A1 | 1.10e-03 | 343 | 211 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.14e-03 | 151 | 211 | 7 | GO:0015085 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.42e-03 | 78 | 211 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA3 AKAP8 SETD6 CHD4 PAGR1 TAF1 THRAP3 FKBP4 EXOSC9 REST ZFPM2 NCOR2 | 1.67e-03 | 417 | 211 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | microtubule binding | MAP1A CLASP2 DYSF HDGFL3 NEFM DST MTCL1 DYNC1I1 KIF16B GAS2L2 | 1.68e-03 | 308 | 211 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 2.05e-03 | 51 | 211 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | tubulin binding | TPR MAP1A CLASP2 DYSF HDGFL3 NEFM DST MTCL1 DYNC1I1 KIF16B GAS2L2 HDGF | 2.07e-03 | 428 | 211 | 12 | GO:0015631 |
| GeneOntologyMolecularFunction | protein kinase A regulatory subunit binding | 2.25e-03 | 25 | 211 | 3 | GO:0034237 | |
| GeneOntologyMolecularFunction | intracellularly cGMP-activated cation channel activity | 2.25e-03 | 7 | 211 | 2 | GO:0005223 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | DDX47 MYO1G MYH9 ABCF1 RSF1 CHD4 DDX10 MDN1 DYNC1I1 VPS4B KIF16B MYO18A CHD7 MLH3 ABCC12 | 2.31e-03 | 614 | 211 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.53e-03 | 26 | 211 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DDX47 ABCF1 RSF1 CHD4 DDX10 MDN1 VPS4B KIF16B MYO18A CHD7 MLH3 ABCC12 | 2.65e-03 | 441 | 211 | 12 | GO:0016887 |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.71e-03 | 55 | 211 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA3 AKAP8 SETD6 CHD4 PAGR1 BCOR TAF1 THRAP3 FKBP4 RAD21 HNF1B EXOSC9 MYBBP1A REST ZFPM2 NCOR2 HDGF | 2.75e-03 | 753 | 211 | 17 | GO:0008134 |
| GeneOntologyBiologicalProcess | chromatin organization | TPR HMGN5 NCOA3 BRPF3 RSF1 NAP1L2 CHD4 BCOR TTF1 HDGFL3 SAFB CFDP1 HTATSF1 TAF1 HDGFL2 RAD21 INO80E MYBBP1A CHD7 TSPY26P REST SMARCC1 PHF14 KDM4A KAT6B INO80B HDGF | 5.13e-07 | 896 | 211 | 27 | GO:0006325 |
| GeneOntologyBiologicalProcess | terminal button organization | 1.29e-06 | 9 | 211 | 4 | GO:0072553 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | TPR HMGN5 NCOA3 BRPF3 RSF1 NAP1L2 CHD4 BCOR TTF1 HDGFL3 SAFB CFDP1 HTATSF1 TAF1 HDGFL2 RAD21 INO80E HNF1B MYBBP1A CHD7 TSPY26P REST SMARCC1 PHF14 KDM4A KAT6B INO80B HDGF | 1.30e-06 | 999 | 211 | 28 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin remodeling | TPR NCOA3 BRPF3 RSF1 NAP1L2 CHD4 BCOR TTF1 HDGFL3 CFDP1 TAF1 HDGFL2 INO80E MYBBP1A CHD7 TSPY26P REST SMARCC1 KDM4A KAT6B INO80B HDGF | 7.95e-06 | 741 | 211 | 22 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.25e-05 | 105 | 211 | 8 | GO:1901879 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 1.31e-05 | 51 | 211 | 6 | GO:0031111 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 1.41e-05 | 176 | 211 | 10 | GO:0070507 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 1.79e-05 | 144 | 211 | 9 | GO:0051261 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 4.07e-05 | 38 | 211 | 5 | GO:0007026 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization to synapse | 5.69e-05 | 8 | 211 | 3 | GO:1902474 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle clustering | 5.69e-05 | 8 | 211 | 3 | GO:2000809 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 6.68e-05 | 42 | 211 | 5 | GO:0031114 | |
| GeneOntologyBiologicalProcess | calcium ion import | 6.68e-05 | 98 | 211 | 7 | GO:0070509 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | RYR2 TRPV2 CACNA1I CACNA1H CACNA1G PLCB3 CHD7 ASPH PLCH1 SLC24A1 | 8.35e-05 | 217 | 211 | 10 | GO:0097553 |
| GeneOntologyBiologicalProcess | presynapse organization | 1.03e-04 | 73 | 211 | 6 | GO:0099172 | |
| GeneOntologyBiologicalProcess | protein localization to microvillus | 1.04e-04 | 2 | 211 | 2 | GO:1904106 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 1.09e-04 | 142 | 211 | 8 | GO:0098659 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.09e-04 | 142 | 211 | 8 | GO:0099587 | |
| GeneOntologyBiologicalProcess | presynaptic membrane assembly | 1.20e-04 | 10 | 211 | 3 | GO:0097105 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 1.20e-04 | 144 | 211 | 8 | GO:0043244 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.28e-04 | 48 | 211 | 5 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.28e-04 | 48 | 211 | 5 | GO:1902656 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 1.64e-04 | 11 | 211 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | cellular response to type II interferon | 1.73e-04 | 114 | 211 | 7 | GO:0071346 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle clustering | 2.17e-04 | 12 | 211 | 3 | GO:2000807 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | TPR MAP1A CLASP2 DYSF HDGFL3 BICD1 CEP97 FKBP4 CCDC40 VPS4B GAS2L2 | 2.27e-04 | 293 | 211 | 11 | GO:0032886 |
| GeneOntologyBiologicalProcess | presynaptic membrane organization | 2.80e-04 | 13 | 211 | 3 | GO:0097090 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 3.06e-04 | 89 | 211 | 6 | GO:1901880 | |
| GeneOntologyBiologicalProcess | right ventricular cardiac muscle tissue morphogenesis | 3.10e-04 | 3 | 211 | 2 | GO:0003221 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component biogenesis | TPR MYH9 GHRL CDC42EP4 GBP1 GBP2 CLASP2 NLGN3 UBE2V2 NLGN2 ARAP1 FNIP2 VPS4B ICE1 NLGN1 EIF4G1 | 3.40e-04 | 582 | 211 | 16 | GO:0044089 |
| GeneOntologyBiologicalProcess | regulation of respiratory gaseous exchange by nervous system process | 3.53e-04 | 14 | 211 | 3 | GO:0002087 | |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | TPR MYH9 GHRL MAP1A CLASP2 BICD1 NLGN3 NLGN2 MTCL1 IPO7 MYO18A ICE1 NLGN1 ASPH EIF4G1 EPB41 | 4.03e-04 | 591 | 211 | 16 | GO:1903829 |
| GeneOntologyBiologicalProcess | regulation of tooth mineralization | 4.39e-04 | 15 | 211 | 3 | GO:0070170 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 4.85e-04 | 36 | 211 | 4 | GO:0007064 | |
| GeneOntologyCellularComponent | chromatin | PDS5B HMGN5 NCOA3 BNC2 BRPF3 AKAP8 TSHZ2 RSF1 NAP1L2 CHD4 CASZ1 WDR43 NFIL3 CFDP1 PDS5A TAF1 RAD21 INO80E HNF1B MYBBP1A ICE1 CHD7 TSPY26P IRX6 REST AKAP8L ZFPM2 NCOR2 FOXD3 VRTN SMARCC1 PHF14 ZFHX3 TNKS1BP1 KDM4A KAT6B INO80B | 2.28e-07 | 1480 | 210 | 37 | GO:0000785 |
| GeneOntologyCellularComponent | ATPase complex | 4.89e-05 | 129 | 210 | 8 | GO:1904949 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.23e-05 | 96 | 210 | 7 | GO:0070603 | |
| Domain | VDCC_T_a1 | 1.36e-06 | 3 | 208 | 3 | IPR005445 | |
| Domain | Carboxylesterase_B_CS | 9.88e-06 | 13 | 208 | 4 | IPR019819 | |
| Domain | Nlgn | 1.34e-05 | 5 | 208 | 3 | IPR000460 | |
| Domain | CARBOXYLESTERASE_B_2 | 1.37e-05 | 14 | 208 | 4 | PS00941 | |
| Domain | COesterase | 1.37e-05 | 14 | 208 | 4 | PF00135 | |
| Domain | CarbesteraseB | 1.37e-05 | 14 | 208 | 4 | IPR002018 | |
| Domain | PWWP | 6.30e-05 | 20 | 208 | 4 | SM00293 | |
| Domain | BEACH | 1.09e-04 | 9 | 208 | 3 | PS50197 | |
| Domain | Beach | 1.09e-04 | 9 | 208 | 3 | PF02138 | |
| Domain | - | 1.09e-04 | 9 | 208 | 3 | 1.10.1540.10 | |
| Domain | Beach | 1.09e-04 | 9 | 208 | 3 | SM01026 | |
| Domain | BEACH_dom | 1.09e-04 | 9 | 208 | 3 | IPR000409 | |
| Domain | PWWP | 1.12e-04 | 23 | 208 | 4 | PF00855 | |
| Domain | PWWP_dom | 1.12e-04 | 23 | 208 | 4 | IPR000313 | |
| Domain | PWWP | 1.33e-04 | 24 | 208 | 4 | PS50812 | |
| Domain | VDCCAlpha1 | 1.54e-04 | 10 | 208 | 3 | IPR002077 | |
| Domain | Ion_trans_dom | 2.89e-04 | 114 | 208 | 7 | IPR005821 | |
| Domain | Ion_trans | 2.89e-04 | 114 | 208 | 7 | PF00520 | |
| Domain | AKAP95 | 3.68e-04 | 3 | 208 | 2 | PF04988 | |
| Domain | AKAP95 | 3.68e-04 | 3 | 208 | 2 | IPR007071 | |
| Domain | ZF_C2H2_AKAP95 | 3.68e-04 | 3 | 208 | 2 | PS51799 | |
| Domain | PHD | 4.79e-04 | 89 | 208 | 6 | SM00249 | |
| Domain | Znf_PHD | 5.39e-04 | 91 | 208 | 6 | IPR001965 | |
| Domain | ZF_PHD_2 | 6.77e-04 | 95 | 208 | 6 | PS50016 | |
| Domain | cNMP-bd_CS | 6.85e-04 | 16 | 208 | 3 | IPR018488 | |
| Domain | ZF_PHD_1 | 7.16e-04 | 96 | 208 | 6 | PS01359 | |
| Domain | 4_1_CTD | 7.30e-04 | 4 | 208 | 2 | PF05902 | |
| Domain | SAB | 7.30e-04 | 4 | 208 | 2 | PF04382 | |
| Domain | Band_4.1_C | 7.30e-04 | 4 | 208 | 2 | IPR008379 | |
| Domain | SAB_dom | 7.30e-04 | 4 | 208 | 2 | IPR007477 | |
| Domain | Parvalbumin | 1.21e-03 | 5 | 208 | 2 | IPR008080 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 2.39e-05 | 32 | 155 | 5 | MM15326 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDS5B TPR NCOA3 ABCF1 AKAP8 PDAP1 CHD4 PAGR1 GPATCH8 BCOR SAFB MDN1 ZBTB21 PLCB3 THRAP3 RANBP2 MYBBP1A COPA ZCCHC8 MYO18A CHD7 REST AKAP8L PWP1 LIG1 NCOR2 SUGP2 ASPH EIF4G1 RBM6 SMARCC1 PPP1R18 PHF14 TNKS1BP1 SCRIB KAT6B LRRFIP1 HDLBP | 2.40e-23 | 774 | 212 | 38 | 15302935 |
| Pubmed | TPP2 PDS5B TPR NES MYH9 ABCF1 RSF1 WDR46 CHD4 EPB41L3 TTF1 DNTTIP2 WDR43 DDX10 NEFM DST MDN1 PDS5A FKBP4 RAD21 RANBP2 MYBBP1A IPO7 COPA ZCCHC8 CHD7 PWP1 SUGP2 EIF4G1 SLTM RBM6 SMARCC1 TNKS1BP1 HDLBP FTSJ3 | 9.00e-23 | 653 | 212 | 35 | 22586326 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PDS5B TPR ZNF609 RSF1 PDAP1 CHD4 EPB41L3 BCOR DNTTIP2 ISY1 WDR43 HDGFL3 DDX10 SAFB RBM19 HTATSF1 PDS5A TAF1 HDGFL2 THRAP3 RAD21 RANBP2 EXOSC9 MYBBP1A ICE1 CHD7 NCOR2 SUGP2 ZSCAN21 EIF4G1 SLTM RBM6 SMARCC1 PHF14 EPB41 INO80B HDLBP FTSJ3 | 3.29e-20 | 954 | 212 | 38 | 36373674 |
| Pubmed | TPP2 TPR NCOA3 NES MYH9 AKAP8 TRIO RPS6KB1 WDR81 CLASP2 CHD4 EPB41L3 BCOR NEFM NLGN3 DST MDN1 UBE2V2 ZBTB21 NLGN2 MTCL1 THRAP3 VGF RANBP2 MYBBP1A CNKSR2 CHD7 AKAP12 NCOR2 FAM171A2 EIF4G1 SMARCC1 PRKAR2B WDFY3 SCRIB LRRFIP1 | 2.75e-18 | 963 | 212 | 36 | 28671696 | |
| Pubmed | TPR NCOA3 MYH9 ABCF1 AKAP8 RPS6KB1 RSF1 NAA10 EPB41L3 SOWAHC WDR43 SAFB MTCL1 THRAP3 FKBP4 RANBP2 MYBBP1A COPA ZCCHC8 RAB11FIP1 LIG1 EIF4G1 RBM6 TNKS1BP1 SCRIB LRRFIP1 FTSJ3 | 9.47e-18 | 503 | 212 | 27 | 16964243 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR MYH9 ABCF1 MAP1A RSF1 PDAP1 CHD4 EPB41L3 BCOR DNTTIP2 WDR43 DDX10 SAFB DST CFDP1 ZBTB21 HTATSF1 SIPA1L2 HDGFL2 FKBP4 RAD21 RANBP2 MYBBP1A ZCCHC8 EGLN1 ICE1 AKAP12 SUGP2 TNKS1BP1 SCRIB EPB41 HDLBP FTSJ3 | 4.20e-16 | 934 | 212 | 33 | 33916271 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | DDX47 HMGN5 MYH9 ZNF609 AKAP8 CHD4 PAGR1 GPATCH8 BCOR TTF1 CASZ1 DNTTIP2 ISY1 WDR43 SAFB DST MDN1 NFIL3 HTATSF1 PDS5A HDGFL2 THRAP3 RAD21 INO80E RANBP2 MYBBP1A COPA ZCCHC8 CHD7 REST NCOR2 ZSCAN21 ASPH SLTM SMARCC1 PHF14 FTSJ3 | 4.52e-15 | 1294 | 212 | 37 | 30804502 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | DDX47 ABCF1 RSF1 WDR46 CHD4 DNTTIP2 WDR43 DDX10 SAFB RBM19 HTATSF1 FKBP4 MYBBP1A COPA IKZF5 PWP1 SUGP2 SLTM PHF14 FTSJ3 | 5.96e-14 | 349 | 212 | 20 | 25665578 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ERICH1 PDS5B HMGN5 RSF1 CHD4 GPATCH8 BCOR CASZ1 DNTTIP2 WDR43 HDGFL3 DDX10 CFDP1 ZBTB21 PDS5A TAF1 HDGFL2 RAD21 IPO7 CHD7 ZSCAN21 SMARCC1 PHF14 KDM4A HDGF | 7.22e-14 | 608 | 212 | 25 | 36089195 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DDX47 NES MYH9 AKAP8 WDR46 CHD4 GPATCH8 DNTTIP2 WDR43 DDX10 SAFB MDN1 RBM19 THRAP3 FKBP4 RAD21 RANBP2 EXOSC9 MYBBP1A COPA ZCCHC8 AKAP8L LIG1 NCOR2 SUGP2 SLTM RBM6 SMARCC1 PHF14 HDGF FTSJ3 | 8.74e-14 | 989 | 212 | 31 | 36424410 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | DDX47 PDS5B NES MYH9 ABCF1 AKAP8 MAP1A PDAP1 CHD4 GPATCH8 EPB41L3 NEFM SAFB DST PDS5A SIPA1L2 THRAP3 RANBP2 MYBBP1A COPA ZCCHC8 MYO18A CHD7 AKAP8L PWP1 SUGP2 NEMF EIF4G1 SLTM RBM6 SMARCC1 TNKS1BP1 | 1.61e-13 | 1082 | 212 | 32 | 38697112 |
| Pubmed | DDX47 PDS5B TPR NCOA3 MYH9 RSF1 CHD4 GPATCH8 ISY1 SAFB MDN1 CFDP1 ZBTB21 HTATSF1 PDS5A TAF1 HDGFL2 THRAP3 FKBP4 RAD21 RANBP2 MYBBP1A IPO7 COPA NCOR2 SUGP2 EIF4G1 SLTM SMARCC1 PHF14 HDGF | 1.69e-13 | 1014 | 212 | 31 | 32416067 | |
| Pubmed | PDS5B NCOA3 RSF1 WDR43 HTATSF1 PDS5A HDGFL2 CEP97 RAD21 RANBP2 EXOSC9 MYBBP1A IPO7 ZCCHC8 CHD7 REST ZFPM2 LIG1 SLTM SMARCC1 PHF14 TNKS1BP1 | 1.82e-13 | 469 | 212 | 22 | 27634302 | |
| Pubmed | PDS5B NES ABCF1 CLASP2 PAGR1 GMIP EPB41L3 HTATSF1 MYBBP1A CNKSR2 AKAP12 PWP1 TNKS1BP1 SCRIB PLCH1 TMCC1 HDGF | 2.41e-13 | 246 | 212 | 17 | 15345747 | |
| Pubmed | TPR NCOA3 MYH9 ZNF609 CHD4 EPB41L3 BCOR NEFM DST ZBTB21 TAF1 RANBP2 ZCCHC8 VPS4B ICE1 CHD7 AKAP8L NCOR2 ZFHX3 TNKS1BP1 | 1.67e-12 | 418 | 212 | 20 | 34709266 | |
| Pubmed | ABCF1 AKAP8 CLASP2 GPATCH8 BCOR TTF1 CASZ1 WDR43 DDX10 DST MDN1 RBM19 PDS5A HDGFL2 RAD21 INO80E RANBP2 EXOSC9 ZCCHC8 ICE1 CHD7 RAB11FIP1 ARPC5 AKAP8L PWP1 ASPH EIF4G1 RBM6 PALM3 PPP1R18 PHF14 ZFHX3 TMCC1 EPB41 INO80B HDLBP | 1.83e-12 | 1497 | 212 | 36 | 31527615 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DDX47 PDS5B TPR MYH9 ABCF1 TRIO WDR46 CLASP2 CHD4 EPB41L3 DNTTIP2 WDR43 DDX10 SAFB MDN1 RBM19 PDS5A THRAP3 FKBP4 RAD21 RANBP2 ADCY4 EXOSC9 MYBBP1A IPO7 COPA PWP1 CLCA2 NEMF EIF4G1 SLTM SMARCC1 HDGF HDLBP FTSJ3 | 2.14e-12 | 1425 | 212 | 35 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DDX47 PDS5B TPR NES MYH9 ABCF1 RSF1 WDR46 CHD4 EPB41L3 DNTTIP2 DDX10 SAFB DST MDN1 RBM19 PDS5A THRAP3 RANBP2 MYBBP1A IPO7 COPA CHD7 AKAP8L NCOR2 SUGP2 ASPH EIF4G1 SLTM SMARCC1 WDFY3 SCRIB HDLBP FTSJ3 | 2.47e-12 | 1353 | 212 | 34 | 29467282 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DDX47 TPP2 TPR MYH9 ABCF1 PDAP1 CLASP2 CHD4 DNTTIP2 ISY1 UBE2H RBM19 HTATSF1 PDS5A PLCB3 MTCL1 HDGFL2 THRAP3 RAD21 RANBP2 EXOSC9 MYBBP1A IPO7 COPA PWP1 NEMF ASPH EIF4G1 SMARCC1 TNKS1BP1 LRRFIP1 HDGF HDLBP FTSJ3 | 8.38e-12 | 1415 | 212 | 34 | 28515276 |
| Pubmed | DDX47 BRPF3 ZNF609 AKAP8 MAP1A RSF1 CHD4 EPB41L3 BCOR SOWAHC DNTTIP2 ISY1 ZBTB21 TAF1 SIPA1L2 INO80E ISLR2 ZCCHC8 RAB11FIP1 AKAP8L NCOR2 MLH3 SUGP2 SMARCC1 ZFHX3 WDFY3 SCRIB KAT6B INO80B FTSJ3 | 1.07e-11 | 1116 | 212 | 30 | 31753913 | |
| Pubmed | DDX47 PDS5B TPR NES MYH9 ABCF1 DNTTIP2 WDR43 SAFB DST HDGFL2 THRAP3 RANBP2 MYBBP1A COPA MYO18A ARPC5 PWP1 EIF4G1 PPP1R18 TNKS1BP1 SCRIB LRRFIP1 | 2.17e-11 | 660 | 212 | 23 | 32780723 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR NES MYH9 ABCF1 AKAP8 NAA10 PDAP1 CLASP2 CHD4 NEFM DST MDN1 PDS5A HDGFL2 FKBP4 RANBP2 EXOSC9 MYBBP1A IPO7 COPA MYO18A ARPC5 AKAP8L AKAP12 NEMF EIF4G1 PRKAR2B HDGF HDLBP FTSJ3 | 2.19e-11 | 1149 | 212 | 30 | 35446349 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | DDX47 TPR MYH9 ABCF1 AKAP8 CHD4 DDX10 SAFB MDN1 RBM19 HTATSF1 HDGFL2 THRAP3 MYBBP1A ZCCHC8 AKAP8L SUGP2 EIF4G1 SMARCC1 PHF14 ZFHX3 FTSJ3 | 2.69e-11 | 605 | 212 | 22 | 28977666 |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | AKAP8 RSF1 PDAP1 CLASP2 CHD4 SAFB HTATSF1 HDGFL2 THRAP3 EXOSC9 TNKS1BP1 HDLBP FTSJ3 | 2.80e-11 | 163 | 212 | 13 | 22113938 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | DDX47 PDS5B TPR NES ABCF1 AKAP8 WDR46 CHD4 DNTTIP2 WDR43 DDX10 SAFB DST MDN1 ZBTB21 THRAP3 FKBP4 RANBP2 EXOSC9 MYBBP1A IPO7 COPA SUGP2 EIF4G1 SLTM SCRIB HDLBP FTSJ3 | 3.78e-11 | 1024 | 212 | 28 | 24711643 |
| Pubmed | NCOA3 ZNF609 AKAP8 PAGR1 GPATCH8 BCOR DDX10 DST CFDP1 ZBTB21 PDS5A TAF1 FKBP4 RAD21 INO80E HNF1B MYBBP1A COPA MYO18A CHD7 AKAP8L ZFPM2 IKZF5 PWP1 NCOR2 SUGP2 ZSCAN21 EIF4G1 RBM6 SMARCC1 ZFHX3 INO80B FTSJ3 | 4.99e-11 | 1429 | 212 | 33 | 35140242 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | DDX47 PDS5B ABCF1 AKAP8 CHD4 TTF1 DNTTIP2 WDR43 DDX10 MDN1 RAD21 EXOSC9 MYBBP1A COPA MYO18A AKAP8L PWP1 SUGP2 NEMF ASPH EIF4G1 RBM6 LRRFIP1 FTSJ3 | 5.71e-11 | 759 | 212 | 24 | 35915203 |
| Pubmed | ERICH1 MYH9 CDC42EP4 AKAP8 CLASP2 CHD4 EPB41L3 RYR2 ARL6 DST RBM19 PDS5A THRAP3 MYBBP1A EGLN1 CNKSR2 AKAP12 LIG1 FAM171A2 SUGP2 ZFHX3 RPGR SCRIB EPB41 | 9.19e-11 | 777 | 212 | 24 | 35844135 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | TPR NCOA3 ZNF609 CHD4 BCOR CASZ1 PDS5A THRAP3 FKBP4 MYBBP1A NCOR2 SUGP2 SMARCC1 ZFHX3 | 9.86e-11 | 220 | 212 | 14 | 35785414 |
| Pubmed | MYH9 AKAP8 EPB41L3 DDX10 NEFM SAFB THRAP3 MYBBP1A ZCCHC8 MYO18A SUGP2 EIF4G1 RBM6 SMARCC1 SCRIB | 1.73e-10 | 274 | 212 | 15 | 34244482 | |
| Pubmed | TPP2 PDS5B NCOA3 ZNF609 ABCF1 NAA10 PDAP1 CHD4 BCOR SAFB NFIL3 ZBTB21 PDS5A THRAP3 FKBP4 RAD21 RANBP2 IPO7 DCPS CHD7 IKZF5 LIG1 NCOR2 SUGP2 ZSCAN21 SMARCC1 HDGF HDLBP | 2.06e-10 | 1103 | 212 | 28 | 34189442 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | TPR MYH9 PDAP1 DNTTIP2 WDR43 DDX10 CFDP1 TAF1 HDGFL2 THRAP3 EXOSC9 MYBBP1A CHD7 SUGP2 ZFHX3 | 2.71e-10 | 283 | 212 | 15 | 30585729 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DDX47 NES MYH9 ABCF1 NAA10 PDAP1 CHD4 EPB41L3 SAFB RBM19 CFDP1 HTATSF1 HDGFL2 THRAP3 FKBP4 RAD21 RANBP2 MYBBP1A DCPS COPA MYO18A AKAP12 NCOR2 EIF4G1 SLTM SMARCC1 SCRIB EPB41 LRRFIP1 HDGF HDLBP | 3.20e-10 | 1367 | 212 | 31 | 32687490 |
| Pubmed | MYO1G TPR RSF1 DNTTIP2 WDR43 MDN1 RBM19 THRAP3 RANBP2 MYBBP1A IPO7 DCPS COPA ARPC5 SLTM FTSJ3 | 3.87e-10 | 340 | 212 | 16 | 29478914 | |
| Pubmed | TPR MYH9 CHD4 SAFB THRAP3 RANBP2 MYBBP1A CPD EIF4G1 SCRIB LRRFIP1 HDLBP FTSJ3 | 4.07e-10 | 202 | 212 | 13 | 24639526 | |
| Pubmed | DDX47 TPR MYH9 AKAP8 CHD4 DNTTIP2 ISY1 SAFB MDN1 THRAP3 RAD21 RANBP2 EXOSC9 MYBBP1A ZCCHC8 ARPC5 AKAP8L PWP1 SUGP2 ASPH EIF4G1 SLTM INO80B FTSJ3 | 5.19e-10 | 847 | 212 | 24 | 35850772 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | DDX47 TPR MYH9 AKAP8 CHD4 EPB41L3 MDN1 MTCL1 THRAP3 ARAP1 RAD21 RANBP2 MYBBP1A IPO7 COPA CHD7 NCOR2 TNKS1BP1 SCRIB HDLBP | 5.99e-10 | 582 | 212 | 20 | 20467437 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ZNF609 AKAP8 MAP1A WDR46 PDAP1 EPB41L3 DYSF ISY1 DDX10 RBM19 THRAP3 INO80E RANBP2 COPA EGLN1 MYO18A AKAP12 SUGP2 EIF4G1 SMARCC1 LRRFIP1 HDLBP | 7.93e-10 | 724 | 212 | 22 | 36232890 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DDX47 TPR MYH9 ABCF1 AKAP8 DNTTIP2 ISY1 WDR43 SAFB DST RBM19 THRAP3 FKBP4 RAD21 EXOSC9 MYBBP1A IPO7 COPA MYO18A PWP1 ASPH EIF4G1 SLTM PPP1R18 TNKS1BP1 SCRIB LRRFIP1 HDLBP FTSJ3 | 8.59e-10 | 1257 | 212 | 29 | 36526897 |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 1.85e-09 | 56 | 212 | 8 | 26919559 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPP2 TPR NES MYH9 ABCF1 EPB41L3 NEFM DST FKBP4 MYBBP1A IPO7 COPA SUGP2 PRKAR2B TNKS1BP1 SCRIB EPB41 HDLBP | 2.04e-09 | 498 | 212 | 18 | 36634849 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | CHD4 TTF1 DNTTIP2 DDX10 SAFB HDGFL2 THRAP3 MYBBP1A SUGP2 SLTM FTSJ3 | 2.05e-09 | 148 | 212 | 11 | 32538781 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | MYH9 ZNF609 MAP1A EPB41L3 BCOR DNTTIP2 SAFB ZBTB21 PDS5A CEP97 RANBP2 EXOSC9 NCOR2 EIF4G1 SLTM TNKS1BP1 HDLBP | 2.48e-09 | 444 | 212 | 17 | 34795231 |
| Pubmed | NCOA3 BNC2 CLASP2 GPATCH8 DYSF WDR43 SAFB ZFAT REST NCOR2 EIF4G1 SLTM SMARCC1 RPGR KAT6B | 2.73e-09 | 335 | 212 | 15 | 15741177 | |
| Pubmed | TPR MYH9 PDAP1 EPB41L3 DST PDS5A RANBP2 MYBBP1A IPO7 COPA EGLN1 MAGI3 CPD AKAP12 EIF4G1 TNKS1BP1 SCRIB PLCH1 EPB41 HDGF HDLBP | 3.01e-09 | 708 | 212 | 21 | 39231216 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NES CDC42EP4 AKAP8 TRIO NAA10 CLASP2 EPB41L3 LYST DST MDN1 ZBTB21 MTCL1 SIPA1L2 ZCCHC8 MAGI3 RAB11FIP1 FAM171A2 EIF4G1 TNKS1BP1 SCRIB PLCH1 TMCC1 EPB41 | 3.71e-09 | 861 | 212 | 23 | 36931259 |
| Pubmed | TPP2 NES MYH9 ABCF1 MAP1A TRIO CLASP2 EPB41L3 NEFM NLGN3 SAFB DST SIPA1L2 THRAP3 DYNC1I1 ADCY4 MYBBP1A COPA MYO18A CNKSR2 ARPC5 SUGP2 EIF4G1 PPP1R18 PRKAR2B TNKS1BP1 SCRIB PLCH1 LRRFIP1 HDLBP | 3.92e-09 | 1431 | 212 | 30 | 37142655 | |
| Pubmed | PDS5B MYH9 GHRL RSF1 PDAP1 CHD4 EPB41L3 LYST DNTTIP2 RYR2 NEFM SAFB DST MDN1 ZBTB21 SIPA1L2 HDGFL2 THRAP3 DYNC1I1 RANBP2 MYBBP1A COPA MYO18A MAGI3 ARPC5 AKAP8L EIF4G1 SMARCC1 PHF14 PLCH1 | 4.67e-09 | 1442 | 212 | 30 | 35575683 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | TPR NES MYH9 ABCF1 PDAP1 RANBP2 MYBBP1A IPO7 EIF4G1 TNKS1BP1 SCRIB EPB41 HDLBP | 7.23e-09 | 256 | 212 | 13 | 33397691 |
| Pubmed | WDR46 GPATCH8 TTF1 WDR43 HTATSF1 MTCL1 THRAP3 RANBP2 MYBBP1A PWP1 SUGP2 FTSJ3 | 7.47e-09 | 210 | 212 | 12 | 16565220 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 COL26A1 TRIO TSHZ2 RPS6KB1 CLASP2 TTF1 CASZ1 BICD1 NLGN3 UBE2H CACNA1H NLGN2 THRAP3 ARAP1 SH3BGR MAGI3 CPD ARPC5 NCOR2 SUGP2 NEMF ASPH RBM6 PHF14 ZFHX3 KAT6B TMCC1 VPS13B EPB41 | 9.65e-09 | 1489 | 212 | 30 | 28611215 |
| Pubmed | MYH9 ABCF1 AKAP8 CLASP2 GPATCH8 ISY1 SAFB HTATSF1 THRAP3 EXOSC9 MYBBP1A COPA ZCCHC8 AKAP8L PWP1 ASPH EIF4G1 SLTM HDLBP FTSJ3 | 1.84e-08 | 713 | 212 | 20 | 29802200 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | TPR ABCF1 CHD4 GPATCH8 SAFB MDN1 PDS5A TAF1 RAD21 RANBP2 EXOSC9 COPA EIF4G1 HDLBP | 1.99e-08 | 332 | 212 | 14 | 32786267 |
| Pubmed | DDX47 WDR46 PDAP1 DNTTIP2 WDR43 DDX10 RBM19 IPO7 PWP1 NEMF PHF14 TNKS1BP1 LRRFIP1 FTSJ3 | 1.99e-08 | 332 | 212 | 14 | 25693804 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DDX47 TPR NCOA3 MYH9 ABCF1 WDR46 CHD4 DNTTIP2 WDR43 DDX10 SAFB DST THRAP3 MYBBP1A IPO7 COPA MYO18A SLTM PPP1R18 SCRIB EPB41 LRRFIP1 FTSJ3 | 2.24e-08 | 949 | 212 | 23 | 36574265 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DDX47 HMGN5 MYH9 ABCF1 AKAP8 WDR46 PDAP1 GPATCH8 DNTTIP2 DDX10 SAFB RBM19 THRAP3 MYBBP1A MYO18A AKAP8L SUGP2 SLTM RBM6 HDLBP FTSJ3 | 2.88e-08 | 807 | 212 | 21 | 22681889 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DDX47 PDS5B HMGN5 MYH9 ABCF1 WDR46 NAA10 CHD4 TTF1 DNTTIP2 WDR43 DDX10 SAFB MDN1 THRAP3 RAD21 RANBP2 MYBBP1A COPA CHD7 AKAP8L PWP1 LIG1 EIF4G1 SMARCC1 PRKAR2B FTSJ3 | 4.07e-08 | 1318 | 212 | 27 | 30463901 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PDS5B TPR ZNF609 AKAP8 NAA10 CLASP2 WDR43 HTATSF1 PDS5A MTCL1 CEP97 THRAP3 ARAP1 RAD21 RANBP2 MYBBP1A COPA AKAP8L AKAP12 EIF4G1 SMARCC1 PPP1R18 TNKS1BP1 SCRIB VPS13B | 4.75e-08 | 1155 | 212 | 25 | 20360068 |
| Pubmed | DDX47 MYH9 ABCF1 WDR46 CHD4 DNTTIP2 WDR43 DDX10 RBM19 RANBP2 EXOSC9 MYBBP1A AKAP8L PWP1 SUGP2 FTSJ3 | 5.53e-08 | 483 | 212 | 16 | 36912080 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | TSHZ2 WDR81 NAA10 DYSF DST MDN1 ZNF648 CACNA1G COL6A3 MYBBP1A KIF16B CHD7 GPR161 SLTM | 6.04e-08 | 363 | 212 | 14 | 14691545 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | CLASP2 CHD4 RBM19 TAF1 RAD21 INO80E RANBP2 ZCCHC8 EIF4G1 SLTM SMARCC1 PPP1R18 FYB1 FTSJ3 | 7.64e-08 | 370 | 212 | 14 | 22922362 |
| Pubmed | TRIO SETD6 CLASP2 CHD4 KLHL41 DYSF DNTTIP2 DST GPC3 NFIL3 TAF1 COL6A3 RANBP2 ZFAT IPO7 AKAP12 | 8.16e-08 | 497 | 212 | 16 | 23414517 | |
| Pubmed | DDX47 MYH9 AKAP8 CLASP2 CHD4 TTF1 WDR43 DDX10 GPC3 RBM19 THRAP3 INO80E EXOSC9 MYBBP1A IPO7 COPA CHD7 AKAP8L PWP1 SUGP2 NEMF ASPH EIF4G1 SMARCC1 LRRFIP1 HDLBP FTSJ3 | 9.02e-08 | 1371 | 212 | 27 | 36244648 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | DDX47 ABCF1 AKAP8 CHD4 GPATCH8 DNTTIP2 RANBP2 EXOSC9 MYBBP1A AKAP8L PWP1 RBM6 SMARCC1 SCRIB FTSJ3 | 1.01e-07 | 440 | 212 | 15 | 34244565 |
| Pubmed | NCOA3 ZNF609 CHD4 PAGR1 BCOR CASZ1 ZBTB21 TAF1 ZCCHC8 CHD7 ZSCAN21 SMARCC1 | 1.10e-07 | 268 | 212 | 12 | 33640491 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | TPR MYH9 CHD4 DDX10 RAD21 RANBP2 MYBBP1A SUGP2 SMARCC1 PHF14 HDLBP FTSJ3 | 1.24e-07 | 271 | 212 | 12 | 32433965 |
| Pubmed | ABCF1 AKAP8 CLASP2 EPB41L3 DNTTIP2 DDX10 MDN1 HTATSF1 SIPA1L2 HDGFL2 FKBP4 RAD21 MYBBP1A IPO7 KIF16B MYO18A CPD RAB11FIP1 AKAP12 FAM171A2 ASPH PRKAR2B SCRIB PLCH1 TMCC1 VPS13B HDLBP FTSJ3 | 1.28e-07 | 1487 | 212 | 28 | 33957083 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | TPP2 TPR ZNF609 CHD4 GPATCH8 BCOR HDGFL2 THRAP3 RANBP2 IPO7 COPA AKAP12 LIG1 NCOR2 EIF4G1 PRKAR2B HDLBP FTSJ3 | 1.65e-07 | 665 | 212 | 18 | 30457570 |
| Pubmed | DDX47 TPP2 TPR ZNF609 ABCF1 PDAP1 GPATCH8 BCOR SIPA1L2 COPA CHD7 AKAP8L NCOR2 VRTN | 1.75e-07 | 396 | 212 | 14 | 26687479 | |
| Pubmed | TPR GPATCH8 BCOR SAFB HTATSF1 HDGFL2 THRAP3 FKBP4 NCOR2 SMARCC1 TNKS1BP1 SCRIB HDGF HDLBP | 1.92e-07 | 399 | 212 | 14 | 35987950 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | MYH9 ABCF1 MAP1A CLASP2 EPB41L3 NEFM THRAP3 DYNC1I1 RANBP2 CNKSR2 PRKAR2B | 2.03e-07 | 231 | 212 | 11 | 16452087 |
| Pubmed | DDX47 MYO1G ABCF1 AKAP8 PDAP1 DDX10 EXOSC9 MYBBP1A AKAP8L ASPH EIF4G1 SLTM SMARCC1 FTSJ3 | 2.16e-07 | 403 | 212 | 14 | 35253629 | |
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 2.23e-07 | 3 | 212 | 3 | 23488970 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 28607166 | ||
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 2.23e-07 | 3 | 212 | 3 | 11230107 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 2.23e-07 | 3 | 212 | 3 | 28972185 | |
| Pubmed | Synaptic Neurexin Complexes: A Molecular Code for the Logic of Neural Circuits. | 2.23e-07 | 3 | 212 | 3 | 29100073 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 11897840 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 26291161 | ||
| Pubmed | Neuroligin-3 is a neuronal adhesion protein at GABAergic and glutamatergic synapses. | 2.23e-07 | 3 | 212 | 3 | 17897391 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 16982420 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 2.23e-07 | 3 | 212 | 3 | 18591418 | |
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 28846697 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 11927664 | ||
| Pubmed | 2.23e-07 | 3 | 212 | 3 | 27217145 | ||
| Pubmed | 2.42e-07 | 103 | 212 | 8 | 32744500 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | RSF1 CHD4 SAFB ZBTB21 THRAP3 RANBP2 CHD7 AKAP8L ZFPM2 NCOR2 SUGP2 SLTM VRTN SMARCC1 | 2.74e-07 | 411 | 212 | 14 | 35182466 |
| Pubmed | DDX47 ABCF1 CLASP2 CHD4 DST FKBP4 MYBBP1A IPO7 COPA AKAP8L PWP1 SUGP2 NEMF ASPH HDLBP FTSJ3 | 2.96e-07 | 547 | 212 | 16 | 37267103 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRIO CLASP2 DYSF LYST CASZ1 DST MDN1 RBM19 TIGD3 UNKL CACNA1H NLGN2 MARVELD3 SIPA1L2 ARAP1 ICE1 C8orf58 NCOR2 SUGP2 EIF4G1 TNKS1BP1 WDFY3 CD276 | 3.37e-07 | 1105 | 212 | 23 | 35748872 |
| Pubmed | ZNF609 AKAP8 GPATCH8 SAFB HTATSF1 THRAP3 COPA ZCCHC8 AKAP8L SUGP2 SLTM | 3.51e-07 | 244 | 212 | 11 | 29884807 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR AKAP8 CHD4 TTF1 CASZ1 NEFM MDN1 NFIL3 CFDP1 ZBTB21 PDS5A THRAP3 RANBP2 COPA NCOR2 FOXD3 SUGP2 EIF4G1 SMARCC1 SCRIB | 3.54e-07 | 857 | 212 | 20 | 25609649 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | ARHGAP30 CLASP2 GPATCH8 GMIP ISY1 SAFB RANBP2 MYBBP1A COPA ZCCHC8 RAB11FIP1 ARPC5 PWP1 SLTM SMARCC1 PPP1R18 HDLBP FTSJ3 | 3.57e-07 | 701 | 212 | 18 | 30196744 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TPP2 PDS5B ABCF1 AKAP8 MAP1A WDR46 CHD4 HTATSF1 PDS5A FKBP4 RANBP2 EXOSC9 MYBBP1A COPA LIG1 SUGP2 SMARCC1 SCRIB | 3.80e-07 | 704 | 212 | 18 | 29955894 |
| Pubmed | TPP2 TPR MYH9 AKAP8 PDS5A FKBP4 MYBBP1A IPO7 COPA AKAP12 GPR161 EIF4G1 RBM6 SMARCC1 LRRFIP1 | 4.40e-07 | 494 | 212 | 15 | 26831064 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | PAG1 MYH9 CDC42EP4 PDAP1 EPB41L3 DST PLCB3 MAGI3 EIF4G1 PALM3 PPP1R18 TNKS1BP1 SCRIB EPB41 LRRFIP1 HDLBP | 4.55e-07 | 565 | 212 | 16 | 25468996 |
| Pubmed | 5.18e-07 | 78 | 212 | 7 | 28611094 | ||
| Pubmed | TPP2 HMGN5 ZNF609 TRIO CLASP2 BCOR FKBP4 RANBP2 MYBBP1A IPO7 COPA CPD RAB11FIP1 AKAP8L NCOR2 FAM171A2 CSPG5 SLTM PPP1R18 SCRIB HDLBP FTSJ3 | 5.44e-07 | 1049 | 212 | 22 | 27880917 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | CHD4 EPB41L3 ZBTB21 PDS5A TAF1 THRAP3 RAD21 RANBP2 MYBBP1A CHD7 AKAP8L IKZF5 SMARCC1 ZFHX3 SCRIB EPB41 | 6.87e-07 | 583 | 212 | 16 | 29844126 |
| Interaction | SIRT7 interactions | TPP2 PDS5B TPR NES MYH9 ABCF1 RSF1 WDR46 CHD4 EPB41L3 TTF1 DNTTIP2 WDR43 DDX10 NEFM DST MDN1 PDS5A FKBP4 RAD21 RANBP2 MYBBP1A IPO7 COPA ZCCHC8 CHD7 PWP1 SUGP2 EIF4G1 SLTM RBM6 SMARCC1 TNKS1BP1 HDLBP FTSJ3 | 6.59e-14 | 744 | 210 | 35 | int:SIRT7 |
| Interaction | SMC5 interactions | PDS5B TPR MYH9 ZNF609 RSF1 PDAP1 CHD4 EPB41L3 BCOR DNTTIP2 ISY1 WDR43 HDGFL3 DDX10 SAFB RBM19 HTATSF1 PDS5A TAF1 HDGFL2 THRAP3 RAD21 RANBP2 EXOSC9 MYBBP1A DCPS ICE1 CHD7 NCOR2 SUGP2 ZSCAN21 EIF4G1 SLTM RBM6 SMARCC1 PHF14 EPB41 INO80B HDLBP FTSJ3 | 1.69e-13 | 1000 | 210 | 40 | int:SMC5 |
| Interaction | RCOR1 interactions | TPR HMGN5 MYH9 CHD4 EPB41L3 BCOR NEFM DST UBE2H ZBTB21 TAF1 RANBP2 HNF1B ZCCHC8 VPS4B ICE1 CHD7 REST AKAP8L NCOR2 SMARCC1 ZFHX3 TNKS1BP1 LRRFIP1 HDGF | 7.40e-11 | 494 | 210 | 25 | int:RCOR1 |
| Interaction | NAA40 interactions | TPP2 TPR HMGN5 MYH9 ABCF1 MAP1A RSF1 PDAP1 CHD4 EPB41L3 BCOR DNTTIP2 WDR43 DDX10 SAFB DST CFDP1 ZBTB21 HTATSF1 SIPA1L2 HDGFL2 FKBP4 RAD21 RANBP2 MYBBP1A ZCCHC8 EGLN1 ICE1 AKAP12 SUGP2 TNKS1BP1 SCRIB EPB41 HDLBP FTSJ3 | 1.47e-10 | 978 | 210 | 35 | int:NAA40 |
| Interaction | CIT interactions | DDX47 PDS5B TPR NES MYH9 ABCF1 RSF1 CLASP2 CHD4 DNTTIP2 WDR43 BICD1 DDX10 NEFM SAFB RBM19 PDS5A CACNA1I HDGFL2 THRAP3 CCDC40 RAD21 RANBP2 EXOSC9 MYBBP1A IPO7 COPA MYO18A MAGI3 ARPC5 AKAP8L PWP1 SUGP2 ASPH EIF4G1 SMARCC1 PPP1R18 TNKS1BP1 SCRIB HDLBP FTSJ3 | 3.80e-09 | 1450 | 210 | 41 | int:CIT |
| Interaction | H3C1 interactions | PDS5B TPR HMGN5 MYH9 RSF1 WDR46 CHD4 DNTTIP2 HDGFL3 DDX10 CFDP1 PDS5A TAF1 HDGFL2 THRAP3 RAD21 HNF1B EXOSC9 MYBBP1A EGLN1 MYO18A CHD7 PWP1 PIEZO2 ZSCAN21 EIF4G1 ZFHX3 KDM4A KAT6B HDGF FTSJ3 | 4.80e-09 | 901 | 210 | 31 | int:H3C1 |
| Interaction | H3-3A interactions | ERICH1 PDS5B HMGN5 MYH9 RSF1 CHD4 GPATCH8 BCOR CASZ1 DNTTIP2 HDGFL3 DDX10 UBE2H CFDP1 ZBTB21 PDS5A TAF1 HDGFL2 THRAP3 RAD21 CHD7 ZSCAN21 SMARCC1 PHF14 KDM4A LRRFIP1 HDGF | 2.01e-08 | 749 | 210 | 27 | int:H3-3A |
| Interaction | POLR1G interactions | PDS5B RSF1 TTF1 DNTTIP2 WDR43 DDX10 MDN1 RBM19 CFDP1 PDS5A TAF1 RAD21 MYBBP1A ZCCHC8 ICE1 CHD7 LIG1 CD3E ZSCAN21 PHF14 FTSJ3 | 4.66e-08 | 489 | 210 | 21 | int:POLR1G |
| Interaction | ZNF330 interactions | PDS5B RSF1 GPATCH8 DNTTIP2 WDR43 DDX10 RBM19 CFDP1 ZBTB21 PDS5A TAF1 RAD21 EXOSC9 MYBBP1A IPO7 CHD7 ZSCAN21 SMARCC1 PHF14 FTSJ3 | 4.90e-08 | 446 | 210 | 20 | int:ZNF330 |
| Interaction | OBSL1 interactions | DDX47 PDS5B TPR NES ABCF1 WDR46 CHD4 DNTTIP2 WDR43 DDX10 SAFB DST MDN1 UBE2H RBM19 SIPA1L2 THRAP3 RANBP2 EXOSC9 MYBBP1A COPA PWP1 SUGP2 NEMF ASPH SLTM SCRIB HDLBP FTSJ3 | 6.91e-08 | 902 | 210 | 29 | int:OBSL1 |
| Interaction | RNF2 interactions | PDS5B ABCF1 AKAP8 RSF1 WDR46 CHD4 PAGR1 BCOR DYSF WDR43 UBE2H UBE2V2 THRAP3 RAD21 VGF RANBP2 MYBBP1A IPO7 COPA ZCCHC8 REST AKAP8L PWP1 SUGP2 SMARCC1 PHF14 LRRFIP1 FTSJ3 | 1.06e-07 | 866 | 210 | 28 | int:RNF2 |
| Interaction | CHD4 interactions | DDX47 TPR MYH9 ABCF1 AKAP8 RSF1 CHD4 GPATCH8 ISY1 DDX10 SAFB MDN1 UBE2H RBM19 HTATSF1 HDGFL2 THRAP3 RAD21 MYBBP1A ZCCHC8 AKAP8L SUGP2 EIF4G1 SMARCC1 PHF14 ZFHX3 LRRFIP1 HDLBP FTSJ3 | 1.58e-07 | 938 | 210 | 29 | int:CHD4 |
| Interaction | CBX3 interactions | ERICH1 PDS5B HMGN5 BRPF3 RSF1 CHD4 BCOR DNTTIP2 WDR43 UBE2H CFDP1 ZBTB21 HTATSF1 PDS5A HDGFL2 FKBP4 CHD7 REST LIG1 ZSCAN21 TNKS1BP1 HDGF HDLBP | 3.04e-07 | 646 | 210 | 23 | int:CBX3 |
| Interaction | MECP2 interactions | DDX47 PDS5B NES MYH9 ABCF1 AKAP8 MAP1A PDAP1 CHD4 GPATCH8 EPB41L3 ISY1 NEFM SAFB DST PDS5A SIPA1L2 THRAP3 RANBP2 MYBBP1A COPA ZCCHC8 MYO18A CHD7 AKAP8L PWP1 SUGP2 NEMF EIF4G1 SLTM RBM6 SMARCC1 PHF14 TNKS1BP1 | 4.95e-07 | 1287 | 210 | 34 | int:MECP2 |
| Interaction | LGR4 interactions | TPR MYH9 RNF19B CHD4 SAFB THRAP3 RANBP2 MYBBP1A CPD EIF4G1 SCRIB LRRFIP1 HDLBP FTSJ3 | 6.91e-07 | 262 | 210 | 14 | int:LGR4 |
| Interaction | DDX23 interactions | PDS5B CHD4 GPATCH8 DNTTIP2 WDR43 DDX10 NEFM SAFB UBE2H RBM19 PDS5A TAF1 HDGFL2 THRAP3 MYBBP1A SLTM RBM6 HDLBP FTSJ3 | 7.23e-07 | 480 | 210 | 19 | int:DDX23 |
| Interaction | NANOG interactions | TPP2 BNC2 ZNF609 AKAP8 CHD4 GPATCH8 BCOR DNTTIP2 MDN1 SIPA1L2 RAD21 RANBP2 MYBBP1A ZCCHC8 CHD7 REST AKAP8L NCOR2 VRTN | 7.46e-07 | 481 | 210 | 19 | int:NANOG |
| Interaction | CSNK2A1 interactions | MYH9 AKAP8 RPS6KB1 RSF1 PDAP1 CLASP2 CHD4 EPB41L3 BCOR LYST SAFB DST UBE2H CFDP1 HTATSF1 TAF1 HDGFL2 THRAP3 FKBP4 EXOSC9 GTF2A1L ZCCHC8 CNKSR2 LIG1 TNKS1BP1 HDGF HDLBP FTSJ3 | 7.81e-07 | 956 | 210 | 28 | int:CSNK2A1 |
| Interaction | NUPR1 interactions | DDX47 PDS5B TPR NES MYH9 ABCF1 DNTTIP2 WDR43 SAFB DST HDGFL2 THRAP3 RANBP2 MYBBP1A COPA MYO18A ARPC5 PWP1 EIF4G1 PPP1R18 TNKS1BP1 SCRIB LRRFIP1 | 7.98e-07 | 683 | 210 | 23 | int:NUPR1 |
| Interaction | FOXL1 interactions | ZNF609 BCOR MDN1 PDS5A RANBP2 COPA CHD7 NCOR2 SUGP2 EIF4G1 ZFHX3 SCRIB | 1.06e-06 | 196 | 210 | 12 | int:FOXL1 |
| Interaction | BRD3 interactions | PDS5B ABCF1 RSF1 CHD4 EPB41L3 DNTTIP2 ISY1 HDGFL3 UBE2H TAF1 INO80E ISLR2 RAB11FIP1 ARPC5 AKAP8L SMARCC1 PLCH1 INO80B FTSJ3 | 1.11e-06 | 494 | 210 | 19 | int:BRD3 |
| Interaction | PHIP interactions | TPR HMGN5 ZNF609 RSF1 CHD4 BCOR SOWAHC TAF1 DCPS AKAP8L NCOR2 ZFHX3 | 1.12e-06 | 197 | 210 | 12 | int:PHIP |
| Interaction | CHD3 interactions | DDX47 TPR MYH9 AKAP8 CHD4 BCOR DDX10 SAFB MDN1 YAE1 HTATSF1 TAF1 THRAP3 RAD21 MYBBP1A ZCCHC8 AKAP8L SUGP2 EIF4G1 SMARCC1 PHF14 ZFHX3 HDLBP FTSJ3 | 1.31e-06 | 757 | 210 | 24 | int:CHD3 |
| Interaction | TERF2IP interactions | ERICH1 PDS5B ZNF609 RSF1 BCOR HDGFL3 DDX10 CFDP1 ZBTB21 HTATSF1 PDS5A TAF1 RAD21 ZCCHC8 CHD7 OCM2 NCOR2 SUGP2 SMARCC1 WDFY3 | 1.44e-06 | 552 | 210 | 20 | int:TERF2IP |
| Interaction | GLDC interactions | MYH9 AKAP8 EPB41L3 DDX10 NEFM SAFB THRAP3 MYBBP1A ZCCHC8 MYO18A SUGP2 EIF4G1 RBM6 SMARCC1 SCRIB | 1.49e-06 | 321 | 210 | 15 | int:GLDC |
| Interaction | HDAC1 interactions | TPR MYH9 ZNF609 CHD4 EPB41L3 BCOR CASZ1 NEFM DST ZBTB21 TAF1 RAD21 RANBP2 HNF1B MYBBP1A ZCCHC8 VPS4B REST AKAP8L ZFPM2 NCOR2 SMARCC1 PRKAR2B PHF14 ZFHX3 TNKS1BP1 KDM4A LRRFIP1 HDGF FTSJ3 | 1.54e-06 | 1108 | 210 | 30 | int:HDAC1 |
| Interaction | IFI16 interactions | DDX47 TPR ABCF1 WDR46 PDAP1 CHD4 DNTTIP2 WDR43 DDX10 SAFB RBM19 FKBP4 MYBBP1A IPO7 COPA PWP1 NEMF SLTM SMARCC1 PHF14 TNKS1BP1 LRRFIP1 FTSJ3 | 1.70e-06 | 714 | 210 | 23 | int:IFI16 |
| Interaction | EGR2 interactions | NCOA3 ZNF609 PAGR1 BCOR UBE2H INO80E CHD7 AKAP8L NCOR2 SMARCC1 ZFHX3 | 1.86e-06 | 171 | 210 | 11 | int:EGR2 |
| Interaction | CEBPA interactions | DDX47 TPP2 PDS5B NCOA3 MYH9 ZNF609 ABCF1 NAA10 PDAP1 CHD4 BCOR SAFB NFIL3 ZBTB21 PDS5A HDGFL2 THRAP3 FKBP4 RAD21 RANBP2 IPO7 DCPS CHD7 IKZF5 LIG1 NCOR2 SUGP2 ZSCAN21 SMARCC1 HDGF HDLBP FTSJ3 | 2.02e-06 | 1245 | 210 | 32 | int:CEBPA |
| Interaction | SOX7 interactions | 2.24e-06 | 82 | 210 | 8 | int:SOX7 | |
| Interaction | EFTUD2 interactions | DDX47 TPP2 TPR MYH9 ABCF1 PDAP1 CLASP2 CHD4 DNTTIP2 ISY1 UBE2H RBM19 HTATSF1 PDS5A PLCB3 MTCL1 HDGFL2 THRAP3 RAD21 RANBP2 EXOSC9 MYBBP1A IPO7 COPA PWP1 NEMF ASPH EIF4G1 RBM6 SMARCC1 TNKS1BP1 LRRFIP1 HDGF HDLBP FTSJ3 | 2.58e-06 | 1449 | 210 | 35 | int:EFTUD2 |
| Interaction | BIRC3 interactions | DDX47 PDS5B TPR MYH9 ABCF1 TRIO WDR46 CHD4 DNTTIP2 WDR43 DDX10 SAFB MDN1 RBM19 PDS5A USP35 THRAP3 FKBP4 RAD21 RANBP2 ADCY4 EXOSC9 MYBBP1A IPO7 COPA NCOR2 CLCA2 EIF4G1 SLTM SMARCC1 HDGF HDLBP FTSJ3 | 3.13e-06 | 1334 | 210 | 33 | int:BIRC3 |
| Interaction | MEN1 interactions | DDX47 PDS5B MYH9 ZNF609 AKAP8 WDR46 CHD4 DNTTIP2 ISY1 DDX10 SAFB MDN1 PDS5A TAF1 THRAP3 RAD21 EXOSC9 MYBBP1A ZCCHC8 AKAP8L PWP1 SUGP2 ASPH EIF4G1 SLTM TNKS1BP1 KAT6B FTSJ3 | 3.26e-06 | 1029 | 210 | 28 | int:MEN1 |
| Interaction | DCPS interactions | MYO1G TPR RSF1 DNTTIP2 WDR43 MDN1 RBM19 THRAP3 RANBP2 MYBBP1A IPO7 DCPS COPA ARPC5 SLTM FTSJ3 | 4.07e-06 | 394 | 210 | 16 | int:DCPS |
| Interaction | HECTD1 interactions | DDX47 PDS5B ABCF1 AKAP8 CHD4 EPB41L3 TTF1 DNTTIP2 WDR43 DDX10 MDN1 TAF1 RAD21 EXOSC9 MYBBP1A IPO7 COPA MYO18A AKAP8L PWP1 SUGP2 NEMF ASPH EIF4G1 RBM6 LRRFIP1 FTSJ3 | 4.26e-06 | 984 | 210 | 27 | int:HECTD1 |
| Interaction | POLR1E interactions | TTF1 CASZ1 WDR43 MDN1 RBM19 TAF1 RANBP2 MYBBP1A DCPS ZCCHC8 ICE1 CHD7 AKAP8L IKZF5 FTSJ3 | 4.29e-06 | 350 | 210 | 15 | int:POLR1E |
| Interaction | SOX2 interactions | NCOA3 ZNF609 AKAP8 MAP1A WDR46 CHD4 BCOR MDN1 SIPA1L2 THRAP3 FKBP4 RAD21 COL6A3 RANBP2 HNF1B EXOSC9 IPO7 COPA ZCCHC8 CHD7 BCDIN3D ARPC5 AKAP8L PWP1 NCOR2 SUGP2 ASPH SLTM SMARCC1 PRKAR2B ZFHX3 PLCH1 KAT6B FTSJ3 | 4.57e-06 | 1422 | 210 | 34 | int:SOX2 |
| Interaction | ABCC12 interactions | 5.31e-06 | 12 | 210 | 4 | int:ABCC12 | |
| Interaction | PYHIN1 interactions | ABCF1 AKAP8 RSF1 CHD4 SAFB MDN1 GPC3 HTATSF1 HDGFL2 EXOSC9 COPA ZCCHC8 IKZF5 SUGP2 PHF14 | 5.64e-06 | 358 | 210 | 15 | int:PYHIN1 |
| Interaction | KDM1A interactions | TPR HMGN5 NCOA3 MYH9 ZNF609 CHD4 EPB41L3 BCOR NEFM DST UBE2H ZBTB21 PDS5A UNKL TAF1 FKBP4 RANBP2 ZCCHC8 VPS4B ICE1 CHD7 AKAP8L NCOR2 SMARCC1 ZFHX3 TNKS1BP1 | 5.76e-06 | 941 | 210 | 26 | int:KDM1A |
| Interaction | BAP1 interactions | TPR NES MYH9 ABCF1 AKAP8 NAA10 PDAP1 CLASP2 CHD4 BCOR NEFM DST MDN1 PDS5A HDGFL2 FKBP4 RANBP2 HNF1B EXOSC9 MYBBP1A IPO7 COPA MYO18A ARPC5 AKAP8L AKAP12 NEMF EIF4G1 PRKAR2B HDGF HDLBP FTSJ3 | 6.23e-06 | 1314 | 210 | 32 | int:BAP1 |
| Interaction | GCM1 interactions | 6.83e-06 | 68 | 210 | 7 | int:GCM1 | |
| Interaction | WFDC5 interactions | 7.61e-06 | 13 | 210 | 4 | int:WFDC5 | |
| Interaction | FTSJ3 interactions | TPP2 NES MAP1A WDR46 CHD4 WDR43 UBE2H RBM19 TAF1 MYBBP1A DCPS PWP1 RBM6 INO80B HDLBP FTSJ3 | 9.64e-06 | 422 | 210 | 16 | int:FTSJ3 |
| Interaction | AKR7L interactions | 1.00e-05 | 72 | 210 | 7 | int:AKR7L | |
| Interaction | CDC5L interactions | DDX47 TPR MYH9 AKAP8 TRIO CHD4 EPB41L3 ISY1 DST MDN1 UBE2H UNKL MTCL1 RANBP2 MYBBP1A IPO7 COPA ZNF35 RBM6 TNKS1BP1 SCRIB HDGF HDLBP FTSJ3 | 1.04e-05 | 855 | 210 | 24 | int:CDC5L |
| Interaction | PHLPP1 interactions | TPR NES MYH9 ABCF1 PDAP1 FKBP4 RANBP2 MYBBP1A IPO7 EIF4G1 TNKS1BP1 SCRIB EPB41 HDLBP | 1.12e-05 | 333 | 210 | 14 | int:PHLPP1 |
| Interaction | DHX40 interactions | AKAP8 GPATCH8 DDX10 SAFB UBE2H TAF1 THRAP3 ZCCHC8 ZSCAN21 SLTM RBM6 FTSJ3 | 1.25e-05 | 249 | 210 | 12 | int:DHX40 |
| Interaction | DEK interactions | CHD4 ISY1 UBE2H THRAP3 RAD21 DCPS SMARCC1 PHF14 LRRFIP1 HDGF FTSJ3 | 1.28e-05 | 209 | 210 | 11 | int:DEK |
| Interaction | FOXP3 interactions | AKAP8 CLASP2 CHD4 RBM19 TAF1 RAD21 INO80E RANBP2 ZCCHC8 SUGP2 EIF4G1 SLTM SMARCC1 PPP1R18 FYB1 FTSJ3 | 1.29e-05 | 432 | 210 | 16 | int:FOXP3 |
| Interaction | XRCC6 interactions | TPR MYH9 PDAP1 CHD4 DYSF DNTTIP2 WDR43 DDX10 UBE2H CFDP1 USP35 TAF1 HDGFL2 THRAP3 FKBP4 ARAP1 HNF1B EXOSC9 MYBBP1A ICE1 CHD7 SUGP2 ZFHX3 HDGF HDLBP | 1.36e-05 | 928 | 210 | 25 | int:XRCC6 |
| Interaction | SUZ12 interactions | HMGN5 NCOA3 CHD4 ISY1 HTATSF1 PDS5A CEP97 THRAP3 RAD21 VGF RANBP2 MYBBP1A COPA CHD7 REST AKAP8L SLTM SMARCC1 PHF14 TNKS1BP1 | 1.43e-05 | 644 | 210 | 20 | int:SUZ12 |
| Interaction | EED interactions | DDX47 PDS5B TPR HMGN5 MYH9 ABCF1 TRIO WDR46 CHD4 BCOR CASZ1 WDR43 DDX10 SAFB RBM19 PDS5A THRAP3 RAD21 RANBP2 MYBBP1A IPO7 DCPS COPA MYO18A CHD7 ARPC5 LIG1 EIF4G1 SLTM PALM3 SMARCC1 HDLBP FTSJ3 | 1.66e-05 | 1445 | 210 | 33 | int:EED |
| Interaction | RBM4B interactions | TTF1 DNTTIP2 WDR43 DDX10 SAFB RBM19 MYBBP1A ZCCHC8 SUGP2 SLTM HDLBP FTSJ3 | 2.08e-05 | 262 | 210 | 12 | int:RBM4B |
| Interaction | LYN interactions | TPP2 PAG1 MYH9 CDC42EP4 TRIO RPS6KB1 EPB41L3 HDGFL3 DST CEP97 THRAP3 EXOSC9 MYBBP1A DCPS RAB11FIP1 AKAP12 FAM171A2 TNKS1BP1 SCRIB PLCH1 EPB41 | 2.20e-05 | 720 | 210 | 21 | int:LYN |
| Interaction | CDK8 interactions | BRPF3 ISY1 DDX10 TAF1 THRAP3 MLH3 SUGP2 ZSCAN21 SMARCC1 HDGF FTSJ3 | 2.24e-05 | 222 | 210 | 11 | int:CDK8 |
| Interaction | TBXT interactions | 2.95e-05 | 116 | 210 | 8 | int:TBXT | |
| Interaction | NUP43 interactions | PDS5B ZNF609 RSF1 GPATCH8 BCOR TTF1 DNTTIP2 RYR2 WDR43 SAFB DST RBM19 RANBP2 ICE1 NCOR2 EIF4G1 SMARCC1 ZFHX3 FTSJ3 | 3.15e-05 | 625 | 210 | 19 | int:NUP43 |
| Interaction | HNF1B interactions | NCOA3 ZNF609 PAGR1 BCOR THRAP3 HNF1B CHD7 NCOR2 SMARCC1 ZFHX3 | 3.18e-05 | 190 | 210 | 10 | int:HNF1B |
| Interaction | H2BC8 interactions | PDS5B MYH9 RSF1 PDAP1 CHD4 BCOR DNTTIP2 WDR43 DDX10 CFDP1 PDS5A HDGFL2 EXOSC9 CHD7 ZSCAN21 SMARCC1 PHF14 HDGF | 3.59e-05 | 576 | 210 | 18 | int:H2BC8 |
| Interaction | SNRNP70 interactions | TPR MYH9 ABCF1 AKAP8 CLASP2 CHD4 GPATCH8 ISY1 SAFB UBE2H HTATSF1 THRAP3 RANBP2 EXOSC9 MYBBP1A COPA ZCCHC8 AKAP8L PWP1 ASPH EIF4G1 SLTM SMARCC1 HDLBP FTSJ3 | 3.59e-05 | 984 | 210 | 25 | int:SNRNP70 |
| Interaction | MYCN interactions | DDX47 PDS5B TPR BRPF3 MYH9 ZNF609 ABCF1 AKAP8 CHD4 GPATCH8 LYST DNTTIP2 WDR43 DDX10 NEFM SAFB RBM19 HDGFL2 THRAP3 MYBBP1A ZCCHC8 CHD7 AKAP8L PWP1 SUGP2 SLTM RBM6 SMARCC1 INO80B HDGF FTSJ3 | 3.84e-05 | 1373 | 210 | 31 | int:MYCN |
| Interaction | DOT1L interactions | DDX47 TPR MYH9 AKAP8 CHD4 DNTTIP2 ISY1 SAFB MDN1 THRAP3 RANBP2 EXOSC9 MYBBP1A ZCCHC8 ARPC5 AKAP8L PWP1 ASPH EIF4G1 SLTM INO80B FTSJ3 | 3.87e-05 | 807 | 210 | 22 | int:DOT1L |
| Interaction | SNRNP40 interactions | ZNF609 AKAP8 RSF1 GPATCH8 BCOR DNTTIP2 ISY1 WDR43 UBE2H ZBTB21 HTATSF1 HDGFL2 NCOR2 SUGP2 RBM6 SMARCC1 ZFHX3 HDLBP FTSJ3 | 4.08e-05 | 637 | 210 | 19 | int:SNRNP40 |
| Interaction | AR interactions | TPR NCOA3 ZNF609 CHD4 PAGR1 BCOR CASZ1 MDN1 ZBTB21 PDS5A TAF1 THRAP3 FKBP4 MYBBP1A ZCCHC8 MYO18A CHD7 RAB11FIP1 NCOR2 MLH3 SUGP2 ZSCAN21 SMARCC1 ZFHX3 KDM4A | 4.10e-05 | 992 | 210 | 25 | int:AR |
| Interaction | FBL interactions | DDX47 BRPF3 RNF19B WDR46 NAP1L2 CHD4 DNTTIP2 WDR43 DDX10 UBE2H RBM19 MYBBP1A IPO7 REST PWP1 EIF4G1 HDGF HDLBP FTSJ3 | 4.25e-05 | 639 | 210 | 19 | int:FBL |
| Interaction | POU5F1 interactions | DDX47 TPP2 TPR ABCF1 AKAP8 PDAP1 CHD4 TAF1 SIPA1L2 RAD21 COPA ZCCHC8 CHD7 NCOR2 FOXD3 SMARCC1 ZFHX3 HDGF | 4.29e-05 | 584 | 210 | 18 | int:POU5F1 |
| Interaction | CENPA interactions | PDS5B RSF1 CASZ1 DNTTIP2 PDS5A TAF1 HDGFL2 RAD21 IPO7 CHD7 ZSCAN21 SMARCC1 PHF14 FTSJ3 | 4.40e-05 | 377 | 210 | 14 | int:CENPA |
| Interaction | RPS6 interactions | ERICH1 PDS5B RPS6KB1 RSF1 WDR46 CHD4 TTF1 DNTTIP2 WDR43 DDX10 UBE2H RBM19 CFDP1 RAD21 MYBBP1A IPO7 REST AKAP8L PWP1 EIF4G1 SLTM HDGF FTSJ3 | 4.41e-05 | 874 | 210 | 23 | int:RPS6 |
| Interaction | CTCFL interactions | 4.51e-05 | 62 | 210 | 6 | int:CTCFL | |
| Interaction | RNF144A interactions | 4.66e-05 | 91 | 210 | 7 | int:RNF144A | |
| Interaction | PAX7 interactions | 4.76e-05 | 124 | 210 | 8 | int:PAX7 | |
| Interaction | FMR1 interactions | NCOA3 AKAP8 CHD4 UBE2H MTCL1 THRAP3 DYNC1I1 RANBP2 MAGI3 CHD7 ZFPM2 NCOR2 FAM171A2 EIF4G1 WDFY3 SCRIB HDLBP | 4.95e-05 | 536 | 210 | 17 | int:FMR1 |
| Interaction | SUMO2 interactions | TPR ABCF1 CHD4 GPATCH8 SAFB DST MDN1 UBE2H ZBTB21 PDS5A TAF1 RAD21 RANBP2 HNF1B EXOSC9 COPA EIF4G1 HDLBP | 5.00e-05 | 591 | 210 | 18 | int:SUMO2 |
| Interaction | U2AF2 interactions | TPR MYH9 PDAP1 GBP1 GBP2 CHD4 GPATCH8 SAFB UBE2H THRAP3 ZCCHC8 LIG1 EIF4G1 EPB41 INO80B LRRFIP1 HDGF HDLBP FTSJ3 | 5.45e-05 | 651 | 210 | 19 | int:U2AF2 |
| Interaction | APEX1 interactions | PDS5B MYH9 RPS6KB1 RSF1 WDR46 CHD4 CASZ1 DNTTIP2 WDR43 DDX10 SAFB UBE2H YIPF1 PDS5A HDGFL2 THRAP3 RAD21 EXOSC9 CPD CHD7 REST LIG1 ZSCAN21 EIF4G1 SMARCC1 RPGR TMCC1 HDGF FTSJ3 | 5.83e-05 | 1271 | 210 | 29 | int:APEX1 |
| Interaction | SOX17 interactions | 6.14e-05 | 95 | 210 | 7 | int:SOX17 | |
| Interaction | DDX21 interactions | AKAP8 WDR46 CHD4 SAFB UBE2H RBM19 PDS5A MTCL1 THRAP3 MYBBP1A DCPS ZCCHC8 REST AKAP8L SUGP2 EIF4G1 SLTM INO80B HDGF FTSJ3 | 6.59e-05 | 718 | 210 | 20 | int:DDX21 |
| Interaction | PHF21A interactions | TPR BCOR NEFM DST TAF1 RANBP2 ZCCHC8 VPS4B ICE1 CHD7 AKAP8L ZFHX3 TNKS1BP1 | 6.73e-05 | 343 | 210 | 13 | int:PHF21A |
| Interaction | ZBTB44 interactions | 7.01e-05 | 67 | 210 | 6 | int:ZBTB44 | |
| Interaction | COIL interactions | DDX47 ERICH1 PDS5B CHD4 BCOR CASZ1 CFDP1 ZBTB21 HTATSF1 PDS5A TAF1 RAD21 DCPS ICE1 CHD7 ZSCAN21 HDLBP | 7.11e-05 | 552 | 210 | 17 | int:COIL |
| Interaction | SNRPA1 interactions | TPR CHD4 GPATCH8 ISY1 UBE2H HTATSF1 THRAP3 RANBP2 DCPS ICE1 REST CNGB3 | 7.72e-05 | 300 | 210 | 12 | int:SNRPA1 |
| Interaction | SP7 interactions | NCOA3 ZNF609 AKAP8 PAGR1 GPATCH8 BCOR HNF1B CHD7 PWP1 NCOR2 ZSCAN21 SMARCC1 | 8.76e-05 | 304 | 210 | 12 | int:SP7 |
| Interaction | KLHL20 interactions | 9.34e-05 | 216 | 210 | 10 | int:KLHL20 | |
| Interaction | TLX1 interactions | 9.45e-05 | 175 | 210 | 9 | int:TLX1 | |
| Interaction | TAF15 interactions | TPR ZNF609 CHD4 SAFB UBE2H HTATSF1 TAF1 THRAP3 DCPS ZCCHC8 REST SLTM SMARCC1 HDLBP | 1.02e-04 | 408 | 210 | 14 | int:TAF15 |
| Interaction | KIF20A interactions | DDX47 PDS5B NES BRPF3 MYH9 ABCF1 AKAP8 CHD4 WDR43 NEFM SAFB RBM19 THRAP3 RANBP2 EXOSC9 MYBBP1A ZFAT COPA MYO18A ARPC5 AKAP8L PIEZO2 SUGP2 PPP1R18 FTSJ3 | 1.05e-04 | 1052 | 210 | 25 | int:KIF20A |
| Interaction | PARP1 interactions | PDS5B HMGN5 RSF1 CHD4 CASZ1 DNTTIP2 WDR43 HDGFL3 DDX10 MDN1 UBE2H RBM19 ZBTB21 PDS5A HDGFL2 THRAP3 RAD21 HNF1B DCPS CHD7 REST LIG1 ZSCAN21 SMARCC1 PHF14 SCRIB HDGF HDLBP FTSJ3 | 1.07e-04 | 1316 | 210 | 29 | int:PARP1 |
| Interaction | SIRT6 interactions | DDX47 ABCF1 AKAP8 CHD4 GPATCH8 BCOR DNTTIP2 PDS5A RAD21 RANBP2 EXOSC9 MYBBP1A AKAP8L PWP1 RBM6 SMARCC1 SCRIB FTSJ3 | 1.08e-04 | 628 | 210 | 18 | int:SIRT6 |
| Interaction | SLX4 interactions | DDX47 PDS5B CHD4 BCOR SAFB MDN1 ZBTB21 PDS5A RAD21 RANBP2 IPO7 AKAP8L MLH3 SUGP2 RBM6 SMARCC1 HDLBP | 1.09e-04 | 572 | 210 | 17 | int:SLX4 |
| Interaction | LCK interactions | PAG1 TRIO EPB41L3 SAFB DST SIPA1L2 FKBP4 EGLN1 KIF16B RAB11FIP1 CD3E FAM171A2 TNKS1BP1 SCRIB PLCH1 | 1.10e-04 | 463 | 210 | 15 | int:LCK |
| Interaction | GATA4 interactions | RSF1 CHD4 SAFB ZBTB21 THRAP3 CHD7 AKAP8L ZFPM2 NCOR2 SUGP2 SLTM VRTN SMARCC1 HDLBP | 1.10e-04 | 411 | 210 | 14 | int:GATA4 |
| Interaction | PRMT1 interactions | DDX47 PDS5B TPR NCOA3 MYH9 ABCF1 AKAP8 PDAP1 CLASP2 EPB41L3 NEFM SAFB UBE2H THRAP3 EXOSC9 MYBBP1A IPO7 AKAP8L PWP1 EIF4G1 WDFY3 LRRFIP1 HDLBP | 1.11e-04 | 929 | 210 | 23 | int:PRMT1 |
| Interaction | FOXQ1 interactions | 1.18e-04 | 141 | 210 | 8 | int:FOXQ1 | |
| Interaction | KCNA3 interactions | TPR MYH9 PDAP1 EPB41L3 DST PDS5A RANBP2 MYBBP1A IPO7 COPA EGLN1 MYO18A MAGI3 CPD AKAP12 EIF4G1 TNKS1BP1 SCRIB PLCH1 EPB41 HDGF HDLBP | 1.18e-04 | 871 | 210 | 22 | int:KCNA3 |
| Interaction | KCTD13 interactions | TPP2 NES MYH9 ABCF1 MAP1A TRIO CLASP2 EPB41L3 NEFM NLGN3 DST SIPA1L2 CEP97 THRAP3 DYNC1I1 ADCY4 MYBBP1A COPA MYO18A CNKSR2 ARPC5 SUGP2 EIF4G1 PPP1R18 PRKAR2B TNKS1BP1 SCRIB PLCH1 LRRFIP1 HDLBP | 1.23e-04 | 1394 | 210 | 30 | int:KCTD13 |
| Interaction | TLX2 interactions | 1.24e-04 | 142 | 210 | 8 | int:TLX2 | |
| Interaction | BRD7 interactions | DDX47 HMGN5 PAG1 MYH9 ABCF1 GPATCH8 THRAP3 HNF1B EXOSC9 MYBBP1A CHD7 AKAP8L PWP1 NEMF ASPH EIF4G1 SMARCC1 FTSJ3 | 1.29e-04 | 637 | 210 | 18 | int:BRD7 |
| Interaction | TOP1 interactions | TPR AKAP8 RSF1 CHD4 ISY1 SAFB UBE2H CFDP1 THRAP3 DCPS ZCCHC8 PWP1 LIG1 SLTM RBM6 SMARCC1 PHF14 HDGF HDLBP | 1.31e-04 | 696 | 210 | 19 | int:TOP1 |
| Interaction | LHX2 interactions | 1.33e-04 | 183 | 210 | 9 | int:LHX2 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 4.18e-05 | 9 | 146 | 3 | 1230 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 3.23e-04 | 17 | 146 | 3 | 486 | |
| GeneFamily | Erythrocyte membrane protein band 4.1|FERM domain containing | 3.84e-04 | 4 | 146 | 2 | 951 | |
| GeneFamily | SIBLING family | 6.37e-04 | 5 | 146 | 2 | 1279 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 7.10e-04 | 22 | 146 | 3 | 579 | |
| GeneFamily | PHD finger proteins | 8.12e-04 | 90 | 146 | 5 | 88 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 8.79e-04 | 53 | 146 | 4 | 532 | |
| GeneFamily | Intermediate filaments Type IV | 9.51e-04 | 6 | 146 | 2 | 611 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.17e-03 | 26 | 146 | 3 | 253 | |
| GeneFamily | WD repeat domain containing | 1.32e-03 | 262 | 146 | 8 | 362 | |
| GeneFamily | PDZ domain containing | 1.48e-03 | 152 | 146 | 6 | 1220 | |
| GeneFamily | Cyclic nucleotide gated channels | 2.79e-03 | 10 | 146 | 2 | 250 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | BNC2 ZNF609 TSHZ2 CASZ1 ZNF648 ZBTB21 ZFAT ZIM3 ZFPM2 IKZF5 ZNF35 ZSCAN21 ZFHX3 | 5.48e-03 | 718 | 146 | 13 | 28 |
| GeneFamily | INO80 complex |SRCAP complex | 6.35e-03 | 15 | 146 | 2 | 595 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.35e-03 | 15 | 146 | 2 | 529 | |
| GeneFamily | Zinc fingers C2HC-type|PHD finger proteins|Lysine acetyltransferases | 7.22e-03 | 16 | 146 | 2 | 66 | |
| GeneFamily | Potassium voltage-gated channel subfamily J | 7.22e-03 | 16 | 146 | 2 | 276 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | PDS5B NCOA3 TRIO CLASP2 GPATCH8 WDR43 BICD1 DDX10 DST MDN1 PDS5A MTCL1 RANBP2 IPO7 NCOR2 RBM6 PHF14 ZFHX3 RPGR WDFY3 KAT6B TMCC1 VPS13B LRRFIP1 | 1.34e-07 | 856 | 212 | 24 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 4.13e-07 | 84 | 212 | 8 | M13008 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 4.53e-07 | 85 | 212 | 8 | M10575 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | BNC2 WDR46 PDAP1 CHD4 RBM19 FKBP4 INO80E MYBBP1A NEMF ASPH EIF4G1 SLTM SMARCC1 PRKAR2B FTSJ3 | 1.32e-06 | 408 | 212 | 15 | M11891 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 1.43e-06 | 133 | 212 | 9 | M8880 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | BNC2 WDR46 PDAP1 CHD4 RBM19 FKBP4 INO80E MYBBP1A NEMF ASPH EIF4G1 SLTM SMARCC1 PRKAR2B FTSJ3 | 1.63e-06 | 415 | 212 | 15 | MM1028 |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_DN | 1.83e-06 | 137 | 212 | 9 | MM990 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL | BNC2 MAP1A GBP2 SOWAHC CASZ1 BICD1 C17orf75 UBE2H NFIL3 CACNA1H PLCB3 MTCL1 SIPA1L2 CPD GPR161 MACROD2 PRKAR2B | 6.78e-06 | 589 | 212 | 17 | M45662 |
| Coexpression | TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL | MYO1G MYH9 RNF19B GBP1 GBP2 EPB41L3 DYSF DNTTIP2 FNIP2 RANBP2 IPO7 CPD RAB20 ARPC5 NCOR2 ASPH EIF4G1 PPP1R18 WDFY3 | 7.50e-06 | 724 | 212 | 19 | M41700 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYO1G PDS5B TPR NCOA3 PAG1 MYH9 ZNF609 RSF1 GBP2 ARHGAP30 GPATCH8 GMIP LYST DNTTIP2 TRPV2 PDS5A THRAP3 RAD21 RANBP2 ICE1 REST ARPC5 CD3E NEMF PPP1R18 KAT6B FYB1 VPS13B LRRFIP1 | 1.10e-05 | 1492 | 212 | 29 | M40023 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | NCOA3 MAP1A RNF19B NAP1L2 CLASP2 EPB41L3 LYST NEFM DST CACNA1H SIPA1L2 FKBP4 FNIP2 RANBP2 IPO7 CPD CHD7 RAB11FIP1 NCOR2 PRKAR2B KAT6B | 3.03e-05 | 946 | 212 | 21 | M39169 |
| Coexpression | GSE3982_DC_VS_NEUTROPHIL_DN | 3.45e-05 | 197 | 212 | 9 | M5462 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_UP | 3.73e-05 | 199 | 212 | 9 | M4945 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_BCELL_UP | 3.88e-05 | 200 | 212 | 9 | M5515 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | ERICH1 TPP2 PDS5B INHBA RPS6KB1 PDAP1 DNTTIP2 WDR43 DDX10 SAFB ALPK3 PDS5A TAF1 RAD21 HNF1B VPS4B ANXA13 CNKSR2 ICE1 ARPC5 GPR161 RBM6 KDM4A SLC24A1 EPB41 LRRFIP1 | 6.48e-05 | 1394 | 212 | 26 | M9585 |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 7.16e-05 | 86 | 212 | 6 | M39248 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | ERICH1 TPP2 MYH9 TRIO BCOR DNTTIP2 WDR43 DDX10 GPC3 YAE1 CEP97 COPA SH3BGR VPS4B MYO18A CHD7 NLGN1 NCOR2 WDFY3 VPS13B LRRFIP1 | 7.61e-05 | 1009 | 212 | 21 | M157 |
| Coexpression | VERHAAK_GLIOBLASTOMA_PRONEURAL | 1.02e-04 | 177 | 212 | 8 | M2115 | |
| Coexpression | NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER | 1.17e-04 | 94 | 212 | 6 | M18108 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_UP | 1.19e-04 | 181 | 212 | 8 | M2641 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | INHBA CHD4 NLGN3 TAF1 SIPA1L2 THRAP3 FKBP4 MYBBP1A REST FAM171A2 CSPG5 ZFHX3 TNKS1BP1 | 1.20e-04 | 467 | 212 | 13 | M1347 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | NCOA3 INHBA RNF19B RSF1 GPATCH8 LYST DST UBE2H NFIL3 FKBP4 VPS4B RAB11FIP1 AKAP8L IKZF5 GPR161 KDM4A WDFY3 TMCC1 | 1.35e-04 | 822 | 212 | 18 | M6782 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | TPP2 TPR HMGN5 NES ABCF1 SETD6 RPS6KB1 RSF1 WDR46 PDAP1 CHD4 SOWAHC TTF1 DNTTIP2 HDGFL3 BICD1 DDX10 ARL6 NEFM MDN1 UBE2V2 YAE1 KCNJ5 PDS5A THRAP3 CCDC40 EXOSC9 IPO7 CHD7 LIG1 OCM NEMF SLTM PALM3 SMARCC1 PHF14 ZFHX3 RPGR EPB41 FTSJ3 | 2.54e-09 | 1459 | 208 | 40 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | TPP2 TPR HMGN5 ABCF1 SETD6 RPS6KB1 RSF1 WDR46 PDAP1 CHD4 SOWAHC TTF1 DNTTIP2 HDGFL3 BICD1 DDX10 ARL6 MDN1 UBE2V2 YAE1 PDS5A THRAP3 CCDC40 EXOSC9 IPO7 LIG1 OCM NEMF SLTM SMARCC1 PHF14 ZFHX3 RPGR EPB41 FTSJ3 | 2.03e-08 | 1257 | 208 | 35 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | HMGN5 ABCF1 RSF1 PDAP1 KLHL41 DYSF DNTTIP2 DST PDS5A CCDC40 RANBP2 IPO7 CHD7 NEMF SLTM RBM6 PALM3 SMARCC1 EPB41 FTSJ3 | 4.10e-08 | 469 | 208 | 20 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | TPR HMGN5 ABCF1 RSF1 WDR46 PDAP1 DNTTIP2 WDR43 BICD1 DDX10 ARL6 NLGN3 MDN1 UBE2V2 YAE1 RBM19 MTCL1 CCDC40 ZMYND15 EXOSC9 MYBBP1A IPO7 CHD7 PWP1 LIG1 THBS3 ZNF35 NEMF SLTM SMARCC1 PLCH1 FTSJ3 | 1.19e-07 | 1164 | 208 | 32 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | TPR HMGN5 ABCF1 RSF1 WDR46 PDAP1 DNTTIP2 WDR43 BICD1 DDX10 ARL6 NLGN3 MDN1 UBE2V2 YAE1 RBM19 MTCL1 CCDC40 ZMYND15 EXOSC9 MYBBP1A IPO7 CHD7 RAB11FIP1 PWP1 LIG1 THBS3 ZNF35 NEMF SLTM SMARCC1 PLCH1 FTSJ3 | 1.01e-06 | 1347 | 208 | 33 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | HMGN5 NES BNC2 ABCF1 AKAP8 MAP1A INHBA PDAP1 DNTTIP2 BICD1 NEFM SAFB MDN1 SIPA1L2 COL6A3 RANBP2 CHD7 NLGN1 RNF227 NEMF SLTM PALM3 PHF14 PLCH1 KAT6B FYB1 EPB41 | 1.32e-06 | 983 | 208 | 27 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPP2 ABCF1 RSF1 PDAP1 DNTTIP2 SAFB PDS5A THRAP3 CCDC40 RANBP2 IPO7 MAGI3 CHD7 NEMF SLTM RBM6 SMARCC1 EPB41 FTSJ3 | 1.34e-06 | 532 | 208 | 19 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | TPR HMGN5 NES BRPF3 ZNF609 ABCF1 MAP1A RSF1 WDR46 WDR81 PDAP1 GPATCH8 BCOR BICD1 NEFM NLGN3 UBE2V2 YAE1 CACNA1H CEP97 THRAP3 CCDC40 EXOSC9 CHD7 RNF227 LIG1 THBS3 SLTM PALM3 PHF14 WDFY3 PLCH1 EPB41 | 1.46e-06 | 1370 | 208 | 33 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#1 | HMGN5 RSF1 PDAP1 KLHL41 BICD1 DST CCDC40 CHD7 NEMF SLTM RBM6 EPB41 FTSJ3 | 1.78e-06 | 259 | 208 | 13 | Facebase_RNAseq_e8.5_Floor Plate_1000_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | HMGN5 ABCF1 PDAP1 SOWAHC SAFB PDS5A RANBP2 IPO7 CHD7 NEMF SLTM PALM3 PHF14 RPGR | 2.55e-06 | 311 | 208 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TPP2 TPR HMGN5 BNC2 ABCF1 RSF1 PDAP1 CHD4 DNTTIP2 HDGFL3 BICD1 DDX10 MDN1 GPC3 UBE2V2 CACNA1G THRAP3 CCDC40 IPO7 CNKSR2 CHD7 LIG1 ZSCAN21 NEMF SLTM SMARCC1 PHF14 ZFHX3 RPGR EPB41 | 4.35e-06 | 1241 | 208 | 30 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | TPP2 TPR HMGN5 BNC2 ABCF1 RSF1 PDAP1 CHD4 DNTTIP2 HDGFL3 BICD1 DDX10 MDN1 GPC3 UBE2V2 KCNJ5 CACNA1G THRAP3 CCDC40 IPO7 SH3BGR CNKSR2 CHD7 LIG1 ZSCAN21 NEMF SLTM PALM3 SMARCC1 PHF14 ZFHX3 RPGR EPB41 | 6.41e-06 | 1468 | 208 | 33 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | BNC2 COL26A1 TRIO NAP1L2 EPB41L3 HDGFL3 NEFM GPC3 CACNA1H DYNC1I1 ARAP1 COL6A3 TSPY26P AKAP12 ZFPM2 THBS3 PIEZO2 FAM171A2 PRKAR2B ZFHX3 KAT6B | 3.53e-05 | 791 | 208 | 21 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TPP2 TPR HMGN5 BNC2 RSF1 PDAP1 CHD4 SOWAHC HDGFL3 NEFM MDN1 UBE2V2 CACNA1G THRAP3 CCDC40 ZMYND15 IPO7 CNKSR2 CHD7 C8orf58 OCM ASPH SLTM SMARCC1 PHF14 ZFHX3 RPGR EPB41 | 3.83e-05 | 1252 | 208 | 28 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | PDS5B NCOA3 BNC2 PAG1 RSF1 CLASP2 EPB41L3 RYR2 C17orf75 COPA CPD EIF4G1 SMARCC1 HDLBP | 3.97e-05 | 397 | 208 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | HMGN5 NES ABCF1 MAP1A PDAP1 SOWAHC BICD1 DDX10 NEFM SAFB PDS5A MTCL1 CEP97 RANBP2 IPO7 EGLN1 CHD7 NLGN1 NEMF SLTM PALM3 PHF14 RPGR PLCH1 | 4.05e-05 | 989 | 208 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | PDS5B NCOA3 BNC2 PAG1 RSF1 NAP1L2 GBP1 CLASP2 EPB41L3 RYR2 C17orf75 MTCL1 COPA SH3BGR CPD ZFPM2 CLCA2 EIF4G1 SMARCC1 ARMH4 HDLBP | 5.06e-05 | 811 | 208 | 21 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | MYO1G TPR HMGN5 ABCF1 RSF1 WDR46 PDAP1 GPATCH8 DNTTIP2 WDR43 BICD1 DDX10 ARL6 MDN1 UBE2V2 YAE1 MTCL1 CEP97 CCDC40 MYBBP1A DCPS AKAP12 LIG1 THBS3 SLTM SMARCC1 PLCH1 LRRFIP1 FTSJ3 | 7.45e-05 | 1371 | 208 | 29 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | TPP2 PDS5B MYH9 RPS6KB1 GBP1 CLASP2 PAGR1 EPB41L3 DST TRPV2 PLCB3 COL6A3 SH3BGR CPD AKAP12 ZFPM2 ASPH MACROD2 PRKAR2B HDLBP | 7.64e-05 | 772 | 208 | 20 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | ABCF1 AKAP8 PDAP1 TTF1 DNTTIP2 BICD1 NEFM SAFB DST SIPA1L2 RANBP2 CHD7 NLGN1 RNF227 NEMF SLTM PHF14 KAT6B | 8.31e-05 | 654 | 208 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | PDS5B TRIO RPS6KB1 CHD4 GPATCH8 BICD1 ARL6 TIGD3 TAF1 RAD21 FNIP2 EXOSC9 IL17RC CHD7 LIG1 RPGR WDFY3 | 8.38e-05 | 595 | 208 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 9.46e-05 | 186 | 208 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ABCF1 AKAP8 DNTTIP2 BICD1 NEFM SAFB SIPA1L2 RANBP2 CHD7 NLGN1 NEMF KAT6B | 1.01e-04 | 328 | 208 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | MYO1G TPR HMGN5 NES ZNF609 AKAP8 MAP1A WDR81 PDAP1 BCOR BICD1 NEFM NLGN3 FNDC1 RBM19 PDS5A CACNA1H CCDC40 CHD7 PALM3 PLCH1 TMCC1 EPB41 | 1.07e-04 | 986 | 208 | 23 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | BNC2 MAP1A INHBA RNF19B GBP1 GBP2 EPB41L3 RYR2 NEFM GPC3 NFIL3 CACNA1G COL6A3 CNKSR2 RNF227 ZFPM2 CLCA2 KAT6B CDH12 ARMH4 | 1.18e-04 | 797 | 208 | 20 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.20e-04 | 192 | 208 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | BNC2 TRIO EPB41L3 HDGFL3 GPC3 CACNA1H COL6A3 TSPY26P ZFPM2 THBS3 PIEZO2 FAM171A2 ZFHX3 | 1.25e-04 | 388 | 208 | 13 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | TPR PAG1 MYH9 TRIO CLASP2 PAGR1 GPATCH8 EPB41L3 CPD EPB41 HDLBP | 2.69e-04 | 312 | 208 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | TPR HMGN5 NES ABCF1 MAP1A PDAP1 GBP1 TTF1 BICD1 NEFM KCNJ5 TIGD3 MARVELD3 CEP97 THRAP3 CCDC40 IPO7 CHD7 NLGN1 OCM CSPG5 SLTM SMARCC1 PHF14 RPGR PLCH1 EPB41 FTSJ3 | 2.99e-04 | 1414 | 208 | 28 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | HMGN5 NCOA3 BNC2 NAP1L2 GBP2 RYR2 NEFM THRAP3 RAD21 COPA CPD REST ASPH EIF4G1 SMARCC1 ZFHX3 RPGR WDFY3 FTSJ3 | 3.71e-04 | 804 | 208 | 19 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | NES MAP1A PDAP1 BICD1 NEFM SAFB PDS5A MTCL1 CHD7 NLGN1 NEMF SLTM PALM3 PLCH1 | 4.19e-04 | 498 | 208 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | TPR PAG1 MYH9 CLASP2 PAGR1 EPB41L3 RYR2 CPD EIF4G1 SMARCC1 VPS13B HDLBP | 4.37e-04 | 385 | 208 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | HMGN5 NCOA3 BNC2 NAP1L2 PDAP1 GBP2 NEFM CEP97 COPA CPD CHD7 REST EIF4G1 SMARCC1 ZFHX3 KDM4A RPGR WDFY3 FTSJ3 | 4.38e-04 | 815 | 208 | 19 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 4.41e-04 | 65 | 208 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TPR PAG1 MYH9 INHBA CLASP2 PAGR1 EPB41L3 RYR2 NEFM CPD CLCA2 ASPH EIF4G1 SMARCC1 ZFHX3 KAT6B VPS13B ARMH4 HDLBP | 4.58e-04 | 818 | 208 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_200 | 4.58e-04 | 183 | 208 | 8 | gudmap_dev gonad_e11.5_F_GonMes_Sma_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | PDS5B TPR TRIO RPS6KB1 ARL6 YAE1 CFDP1 FNIP2 ICE1 CHD7 REST LIG1 ZFHX3 RPGR WDFY3 | 4.69e-04 | 564 | 208 | 15 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 4.89e-04 | 232 | 208 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 5.91e-04 | 105 | 208 | 6 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_500_K4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.09e-08 | 198 | 212 | 10 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-07 | 187 | 212 | 9 | 7b2cd0c618ed081223343f3bec2244c8723c9a31 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.87e-07 | 193 | 212 | 9 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.04e-07 | 194 | 212 | 9 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.41e-07 | 196 | 212 | 9 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.60e-07 | 197 | 212 | 9 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.60e-07 | 197 | 212 | 9 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.60e-07 | 197 | 212 | 9 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.80e-07 | 198 | 212 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.01e-07 | 199 | 212 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-07 | 200 | 212 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-07 | 200 | 212 | 9 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-07 | 200 | 212 | 9 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-07 | 200 | 212 | 9 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 184 | 212 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.17e-06 | 186 | 212 | 8 | d6c8ce2a32c218dcc63d861cc247152430ed3c8c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 188 | 212 | 8 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 188 | 212 | 8 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.57e-06 | 189 | 212 | 8 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.71e-06 | 190 | 212 | 8 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 3.71e-06 | 190 | 212 | 8 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.16e-06 | 193 | 212 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.33e-06 | 194 | 212 | 8 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 4.33e-06 | 194 | 212 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 4.33e-06 | 194 | 212 | 8 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 4.33e-06 | 194 | 212 | 8 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.66e-06 | 196 | 212 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.84e-06 | 197 | 212 | 8 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.84e-06 | 197 | 212 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 4.84e-06 | 197 | 212 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.84e-06 | 197 | 212 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.84e-06 | 197 | 212 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.03e-06 | 198 | 212 | 8 | df546a9afc0e15398f33c1b511c7281771f9aea0 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 5.03e-06 | 198 | 212 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-06 | 198 | 212 | 8 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 5.03e-06 | 198 | 212 | 8 | 23783572c22c24d9fb8e14dc1f3852d2094157df | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.03e-06 | 198 | 212 | 8 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.22e-06 | 199 | 212 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.22e-06 | 199 | 212 | 8 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 11.5-Distal-Mesenchymal-Mesenchyme_RSPO2+|Distal / Age, Tissue, Lineage and Cell class | 5.22e-06 | 199 | 212 | 8 | cea1b30f3e3a9b4ccbc8b57f82352067be1a1d68 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.12e-06 | 148 | 212 | 7 | fd0d8386b94adb1bdc993fbb44d2d87852bfd7f0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 158 | 212 | 7 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 158 | 212 | 7 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | COVID-CD8-CD8_2|COVID / Condition, Cell_class and T cell subcluster | 1.23e-05 | 161 | 212 | 7 | 307dcc17475413cd9eb70c27bc447f938ee5723d | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_cell|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.39e-05 | 164 | 212 | 7 | e4d43af7eb04d55328791b554bdf3a7ce6818027 | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 1.56e-05 | 167 | 212 | 7 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.82e-05 | 171 | 212 | 7 | f1fdc0ec3399ed6955976d02be7e5fc329a64276 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-05 | 173 | 212 | 7 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.04e-05 | 174 | 212 | 7 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 176 | 212 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.19e-05 | 176 | 212 | 7 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 2.19e-05 | 176 | 212 | 7 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 2.19e-05 | 176 | 212 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 2.27e-05 | 177 | 212 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.27e-05 | 177 | 212 | 7 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-05 | 180 | 212 | 7 | c72f15763ba707189e29c85db533557f01c7fdb1 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.53e-05 | 180 | 212 | 7 | c4068fe47408cfd899131a85fa4b7e5908926f94 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 181 | 212 | 7 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.62e-05 | 181 | 212 | 7 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.72e-05 | 182 | 212 | 7 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-05 | 184 | 212 | 7 | 453295362888c9a59d0e73c7a5b15914c50ff591 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 185 | 212 | 7 | 70de48988c1f8e0809afc8092b663aa439d8e528 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.02e-05 | 185 | 212 | 7 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 185 | 212 | 7 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-05 | 185 | 212 | 7 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 3.02e-05 | 185 | 212 | 7 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-Alveolar_Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass | 3.12e-05 | 186 | 212 | 7 | 3314def702fe6a5056d0dadbb3a587c5d1a16412 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 186 | 212 | 7 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-05 | 186 | 212 | 7 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 186 | 212 | 7 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.23e-05 | 187 | 212 | 7 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.23e-05 | 187 | 212 | 7 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.23e-05 | 187 | 212 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.34e-05 | 188 | 212 | 7 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-05 | 188 | 212 | 7 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.34e-05 | 188 | 212 | 7 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.34e-05 | 188 | 212 | 7 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.34e-05 | 188 | 212 | 7 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 3.46e-05 | 189 | 212 | 7 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.46e-05 | 189 | 212 | 7 | b6d5dec55bf352f6ae19d8f488ae70aa10fb9a8f | |
| ToppCell | RA-14._Fibroblast_III|RA / Chamber and Cluster_Paper | 3.46e-05 | 189 | 212 | 7 | 46e9a58aacd79db5a02898a8c7244e1884adcfd1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.46e-05 | 189 | 212 | 7 | f75cebd4c3e54e297557449ba67ccc8d1a2a14f5 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.58e-05 | 190 | 212 | 7 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.58e-05 | 190 | 212 | 7 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 3.58e-05 | 190 | 212 | 7 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-05 | 191 | 212 | 7 | 89d03c4133dda852a3713c0902a7d67941cf5b21 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.70e-05 | 191 | 212 | 7 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-05 | 191 | 212 | 7 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.70e-05 | 191 | 212 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 191 | 212 | 7 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 191 | 212 | 7 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.70e-05 | 191 | 212 | 7 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 191 | 212 | 7 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.82e-05 | 192 | 212 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.82e-05 | 192 | 212 | 7 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-05 | 192 | 212 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-05 | 192 | 212 | 7 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.82e-05 | 192 | 212 | 7 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.82e-05 | 192 | 212 | 7 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 3.82e-05 | 192 | 212 | 7 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | AKAP8 RNF19B RYR2 BICD1 HTATSF1 PLCB3 TAF1 NCOR2 ASPH RPGR KAT6B INO80B HDLBP | 4.13e-08 | 196 | 212 | 13 | 5288_UP |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | PDS5B ZNF609 TRIO DIPK1A CLASP2 BICD1 KIF16B CHD7 WDFY3 PLCH1 TMCC1 | 7.51e-07 | 174 | 212 | 11 | 7530_DN |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 7.96e-07 | 3 | 212 | 3 | CID010679219 | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | ZNF609 TRIO RNF19B GBP2 CHD4 LYST BICD1 PLCB3 REST AKAP12 RPGR | 1.88e-06 | 191 | 212 | 11 | 5200_DN |
| Drug | Kaempferol [520-18-3]; Down 200; 14uM; MCF7; HT_HG-U133A | ZNF609 PDAP1 BICD1 CACNA1H TAF1 TMUB2 COPA NLGN1 ASPH WDFY3 INO80B | 2.54e-06 | 197 | 212 | 11 | 3579_DN |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | ZNF609 CDC42EP4 INHBA PDAP1 RBM19 HNF1B REST IKZF5 TG SUGP2 ZFHX3 | 2.67e-06 | 198 | 212 | 11 | 2128_UP |
| Drug | themisone | 3.41e-06 | 12 | 212 | 4 | CID000016235 | |
| Drug | chrysene | MYO1G HMGN5 NCOA3 SETD6 PDAP1 CASZ1 FNDC1 MDN1 NFIL3 HTATSF1 MARVELD3 TAF1 THRAP3 ZMYND15 SH3BGR MAGI3 RAB11FIP1 AKAP12 ASPH EIF4G1 RBM6 EPB41 INO80B | 7.23e-06 | 871 | 212 | 23 | ctd:C031180 |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | TPR NCOA3 CHD4 GPATCH8 HTATSF1 RAD21 PWP1 EIF4G1 SMARCC1 KAT6B | 7.28e-06 | 179 | 212 | 10 | 4585_DN |
| Drug | Flunarizine | 7.85e-06 | 5 | 212 | 3 | DB04841 | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.47e-05 | 194 | 212 | 10 | 3606_DN | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 1.47e-05 | 194 | 212 | 10 | 2687_UP | |
| Drug | 3,4-dihydroquinazoline | 1.56e-05 | 6 | 212 | 3 | CID000583065 | |
| Drug | Capsaicin [404-86-4]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.61e-05 | 196 | 212 | 10 | 3372_UP | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | RNF19B RBM19 PLCB3 TAF1 ARAP1 VGF WDFY3 SCRIB SLC24A1 VPS13B | 1.61e-05 | 196 | 212 | 10 | 5438_DN |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A_EA | 1.61e-05 | 196 | 212 | 10 | 1078_UP | |
| Drug | Aminocaproic acid [60-32-2]; Up 200; 30.4uM; PC3; HT_HG-U133A | 1.68e-05 | 197 | 212 | 10 | 7258_UP | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.68e-05 | 197 | 212 | 10 | 6611_DN | |
| Drug | Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 1.76e-05 | 198 | 212 | 10 | 3581_DN | |
| Drug | Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; HL60; HT_HG-U133A | ZNF609 PDAP1 GBP1 CACNA1I PLCB3 DSPP ZFHX3 PLCH1 SLC24A1 INO80B | 1.76e-05 | 198 | 212 | 10 | 2542_DN |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.83e-05 | 199 | 212 | 10 | 7133_DN | |
| Drug | torcetrapib | TPP2 TPR NCOA3 INHBA CHD4 DST NFIL3 ZBTB21 HTATSF1 RAD21 EGLN1 EIF4G1 SMARCC1 | 2.09e-05 | 342 | 212 | 13 | ctd:C483909 |
| Drug | LY215840 | 2.71e-05 | 7 | 212 | 3 | CID000132049 | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 4.40e-05 | 177 | 212 | 9 | 985_DN | |
| Drug | aluminum fluoride | GBP1 GBP2 PAGR1 PLCB3 ADCY4 GTF2A1L COPA TG PRKAR2B WDFY3 PLCH1 | 4.56e-05 | 268 | 212 | 11 | CID000002124 |
| Drug | geldanamycin; Up 200; 1uM; MCF7; HG-U133A | 5.47e-05 | 182 | 212 | 9 | 593_UP | |
| Drug | Digoxin [20830-75-5]; Down 200; 5.2uM; MCF7; HT_HG-U133A | CDC42EP4 PAGR1 ZCCHC2 C17orf75 RAB20 PWP1 MLH3 SLC24A1 TMCC1 | 5.47e-05 | 182 | 212 | 9 | 5324_DN |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 5.70e-05 | 183 | 212 | 9 | 5613_DN | |
| Drug | Cinnarizine | 6.42e-05 | 9 | 212 | 3 | DB00568 | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.02e-05 | 188 | 212 | 9 | 3257_DN | |
| Drug | Azacytidine-5 [320-67-2]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 7.62e-05 | 190 | 212 | 9 | 3348_DN | |
| Drug | Kawain [500-64-1]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 7.62e-05 | 190 | 212 | 9 | 2299_DN | |
| Drug | baclofen | 7.93e-05 | 191 | 212 | 9 | CID000002284 | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A | 7.93e-05 | 191 | 212 | 9 | 6884_UP | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; MCF7; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 3604_DN | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; PC3; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 4308_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 7354_DN | |
| Drug | Fusaric acid [536-69-6]; Down 200; 22.4uM; MCF7; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 4105_DN | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; HL60; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 2397_DN | |
| Drug | Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A | 8.93e-05 | 194 | 212 | 9 | 5293_UP | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; HL60; HT_HG-U133A | 9.29e-05 | 195 | 212 | 9 | 2151_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 9.29e-05 | 195 | 212 | 9 | 3571_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 4100_DN | |
| Drug | Benzonatate [104-31-4]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 5435_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; HL60; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 2534_DN | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 2315_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 5919_UP | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; HL60; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 2740_UP | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; PC3; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 5733_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 9.66e-05 | 196 | 212 | 9 | 1696_DN | |
| Drug | Riboflavine [83-88-5]; Down 200; 10.6uM; HL60; HG-U133A | 9.66e-05 | 196 | 212 | 9 | 1767_DN | |
| Drug | Tocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 7351_UP | |
| Drug | Meglumine [6284-40-8]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 5285_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 6863_UP | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.00e-04 | 197 | 212 | 9 | 1017_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 7500_UP | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.00e-04 | 197 | 212 | 9 | 1012_DN | |
| Drug | Meticrane [1084-65-7]; Down 200; 14.6uM; PC3; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 7282_DN | |
| Drug | Aspartic acid, N-acetyl (R,S) [997-55-7]; Down 200; 22.8uM; MCF7; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 3265_DN | |
| Drug | 17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A | 1.00e-04 | 197 | 212 | 9 | 2673_DN | |
| Drug | SC-58125; Up 200; 10uM; MCF7; HG-U133A | 1.04e-04 | 198 | 212 | 9 | 208_UP | |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 7256_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 2080_DN | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 5835_DN | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 7307_DN | |
| Drug | aspirin, USP; Up 200; 100uM; HL60; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 1145_UP | |
| Drug | Suramin sodium salt; Down 200; 10uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 7501_DN | |
| Drug | Flurandrenolide [1524-88-5]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 2184_DN | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 6356_UP | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 7320_UP | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.04e-04 | 198 | 212 | 9 | 5878_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 6349_UP | |
| Drug | Vinpocetine [42971-09-5]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 5859_DN | |
| Drug | Antazoline hydrochloride [2508-72-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 7128_DN | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; HL60; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 2337_UP | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 2064_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 7279_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 1.08e-04 | 199 | 212 | 9 | 6182_UP | |
| Drug | 2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A | 1.13e-04 | 200 | 212 | 9 | 6227_UP | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 1.13e-04 | 200 | 212 | 9 | 2075_DN | |
| Drug | PHA-00851261E [724719-49-7]; Up 200; 1uM; PC3; HT_HG-U133A | 1.13e-04 | 200 | 212 | 9 | 3776_UP | |
| Drug | Mibefradil | 1.24e-04 | 11 | 212 | 3 | DB01388 | |
| Drug | EBNs | 1.24e-04 | 11 | 212 | 3 | CID000150695 | |
| Drug | rufinamide | 1.45e-04 | 29 | 212 | 4 | CID000129228 | |
| Drug | AC1L2VU3 | 1.65e-04 | 12 | 212 | 3 | CID000129572 | |
| Drug | anacardic acid | 1.66e-04 | 30 | 212 | 4 | CID000167551 | |
| Drug | AC1NB8R3 | 1.81e-04 | 213 | 212 | 9 | CID004489307 | |
| Drug | Mibefradil | 2.12e-04 | 13 | 212 | 3 | ctd:D020748 | |
| Drug | tetralol | 2.12e-04 | 13 | 212 | 3 | CID000010747 | |
| Drug | e De | 2.42e-04 | 33 | 212 | 4 | CID000446232 | |
| Drug | CNS 1145 | 2.42e-04 | 33 | 212 | 4 | CID000190902 | |
| Drug | IHC-64 | 2.42e-04 | 33 | 212 | 4 | CID000162753 | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.43e-04 | 175 | 212 | 8 | 1057_UP | |
| Drug | papaverine | 2.53e-04 | 176 | 212 | 8 | CID000004680 | |
| Drug | SureCN2398996 | 2.57e-04 | 3 | 212 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 2.57e-04 | 3 | 212 | 2 | CID000092154 | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 2.83e-04 | 179 | 212 | 8 | 6951_UP | |
| Drug | SAHA; Up 200; 10uM; MCF7; HT_HG-U133A | 2.94e-04 | 180 | 212 | 8 | 6939_UP | |
| Drug | thioridazine hydrochloride; Up 200; 10uM; HL60; HT_HG-U133A | 2.94e-04 | 180 | 212 | 8 | 1171_UP | |
| Drug | testosterone enanthate | TPR NCOA3 NES WDR46 GBP1 GBP2 CHD4 GPATCH8 HTATSF1 FKBP4 RANBP2 SUGP2 EIF4G1 PRKAR2B PHF14 | 3.41e-04 | 575 | 212 | 15 | ctd:C004648 |
| Disease | Bilateral Wilms Tumor | 4.78e-05 | 29 | 206 | 4 | C2930471 | |
| Disease | Microphthalmia, syndromic 1 | 4.85e-05 | 2 | 206 | 2 | C0796016 | |
| Disease | AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3 | 4.85e-05 | 2 | 206 | 2 | 608175 | |
| Disease | Lenz microphthalmia syndrome | 4.85e-05 | 2 | 206 | 2 | cv:CN305341 | |
| Disease | MICROPHTHALMIA, SYNDROMIC 1 | 4.85e-05 | 2 | 206 | 2 | 309800 | |
| Disease | Microphthalmia, syndromic 1 | 4.85e-05 | 2 | 206 | 2 | cv:C0796016 | |
| Disease | Autoimmune thyroid disease, susceptibility to, 3 | 4.85e-05 | 2 | 206 | 2 | cv:C1842444 | |
| Disease | syndromic microphthalmia 1 (is_implicated_in) | 4.85e-05 | 2 | 206 | 2 | DOID:0111799 (is_implicated_in) | |
| Disease | red blood cell density measurement | RPS6KB1 CHD4 CASZ1 DST UBE2H PLCB3 EXOSC9 ZFAT EGLN1 ZFPM2 TG THBS3 CD3E PALM3 KDM4A FYB1 VPS13B ARMH4 | 5.01e-05 | 880 | 206 | 18 | EFO_0007978 |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 7.03e-05 | 99 | 206 | 6 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Nephroblastoma | 1.14e-04 | 36 | 206 | 4 | C0027708 | |
| Disease | body weight | SETD6 SERTAD4-AS1 BICD1 NFIL3 RBM19 DMP1 ARAP1 HNF1B EXOSC9 ZFAT GTF2A1L DSPP CNKSR2 IL17RC CHD7 NLGN1 BCDIN3D MACROD2 ZFHX3 SCRIB KAT6B | 2.16e-04 | 1261 | 206 | 21 | EFO_0004338 |
| Disease | Autoimmune thyroiditis | 2.88e-04 | 4 | 206 | 2 | C0920350 | |
| Disease | Dentin dysplasia, type 1 | 2.88e-04 | 4 | 206 | 2 | C0399379 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 2.88e-04 | 4 | 206 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | primary hyperaldosteronism (is_implicated_in) | 4.78e-04 | 5 | 206 | 2 | DOID:446 (is_implicated_in) | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 6.89e-04 | 25 | 206 | 3 | DOID:0050589 (implicated_via_orthology) | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 7.14e-04 | 6 | 206 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | hydrocephalus (is_implicated_in) | 7.14e-04 | 6 | 206 | 2 | DOID:10908 (is_implicated_in) | |
| Disease | Abnormality of chromosome segregation | 8.29e-04 | 60 | 206 | 4 | HP_0002916 | |
| Disease | thrombocytopenia (is_implicated_in) | 8.67e-04 | 27 | 206 | 3 | DOID:1588 (is_implicated_in) | |
| Disease | Achromatopsia | 9.95e-04 | 7 | 206 | 2 | C0152200 | |
| Disease | risk-taking behaviour | BNC2 TSHZ2 RYR2 RBM19 CACNA1G GTF2A1L NLGN1 REST RNF227 THBS3 MACROD2 ZFHX3 CD276 ARMH4 | 1.02e-03 | 764 | 206 | 14 | EFO_0008579 |
| Disease | Headache | 1.06e-03 | 64 | 206 | 4 | HP_0002315 | |
| Disease | total blood protein measurement | 1.30e-03 | 449 | 206 | 10 | EFO_0004536 | |
| Disease | osteoarthritis, spine, body mass index | 1.32e-03 | 8 | 206 | 2 | EFO_0004340, EFO_1000787 | |
| Disease | urate measurement, bone density | TSHZ2 CLASP2 CASZ1 DDX10 FNDC1 MAGI3 AKAP12 TG RBM6 PRKAR2B KAT6B CDH12 | 1.45e-03 | 619 | 206 | 12 | EFO_0003923, EFO_0004531 |
| Disease | urinary albumin to creatinine ratio | 1.66e-03 | 179 | 206 | 6 | EFO_0007778 | |
| Disease | infection | 1.69e-03 | 9 | 206 | 2 | EFO_0000544 | |
| Disease | tryptase beta-2 measurement | 1.69e-03 | 9 | 206 | 2 | EFO_0008306 | |
| Disease | Kartagener Syndrome | 1.86e-03 | 35 | 206 | 3 | C0022521 | |
| Disease | Ciliary Dyskinesia, Primary, 1, With Or Without Situs Inversus | 1.86e-03 | 35 | 206 | 3 | C4551906 | |
| Disease | Polynesian Bronchiectasis | 1.86e-03 | 35 | 206 | 3 | C4317124 | |
| Disease | pulse pressure measurement | BNC2 BRPF3 INHBA SETD6 RPS6KB1 GPATCH8 ZCCHC2 DYSF CASZ1 FNDC1 CFDP1 MARVELD3 CEP97 COL6A3 ZFAT ZFPM2 CD3E PIEZO2 FAM171A2 ZFHX3 | 1.86e-03 | 1392 | 206 | 20 | EFO_0005763 |
| Disease | cortical thickness | PDS5B BNC2 COL26A1 INHBA DYSF HDGFL3 USP35 MTCL1 FNIP2 ANXA13 CHD7 USH1C ARPC5 TG THBS3 MACROD2 PLCH1 | 2.18e-03 | 1113 | 206 | 17 | EFO_0004840 |
| Disease | Autistic Disorder | 2.48e-03 | 261 | 206 | 7 | C0004352 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 3.06e-03 | 12 | 206 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | smoking status measurement | BNC2 TSHZ2 INHBA SERTAD4-AS1 RYR2 HDGFL3 HDGFL2 CHD7 NLGN1 REST CSPG5 SMARCC1 ZFHX3 KDM4A CDH12 CD276 ARMH4 | 3.33e-03 | 1160 | 206 | 17 | EFO_0006527 |
| Disease | Alzheimer disease, cognitive decline measurement, Cognitive impairment | 3.60e-03 | 13 | 206 | 2 | EFO_0007710, HP_0100543, MONDO_0004975 | |
| Disease | forced expiratory volume | BNC2 CASZ1 RYR2 DST GPC3 UBE2V2 CFDP1 MTCL1 FKBP4 ZFAT REST NCOR2 VRTN | 3.81e-03 | 789 | 206 | 13 | EFO_0004314 |
| Disease | Disorder of eye | 3.85e-03 | 212 | 206 | 6 | C0015397 | |
| Disease | cleft lip | 3.95e-03 | 284 | 206 | 7 | EFO_0003959 | |
| Disease | nephroblastoma (is_implicated_in) | 4.18e-03 | 14 | 206 | 2 | DOID:2154 (is_implicated_in) | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 4.18e-03 | 14 | 206 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | HMGN5 NCOA3 CASZ1 PDS5A HNF1B MYBBP1A IL17RC CHD7 ZFHX3 CDH12 CD276 | 4.21e-03 | 616 | 206 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | HMGN5 NCOA3 CASZ1 PDS5A HNF1B MYBBP1A IL17RC CHD7 ZFHX3 CDH12 CD276 | 4.21e-03 | 616 | 206 | 11 | C0376358 |
| Disease | Primary Ciliary Dyskinesia | 4.34e-03 | 47 | 206 | 3 | C4551720 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 4.37e-03 | 152 | 206 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | hepatoblastoma (is_marker_for) | 4.80e-03 | 15 | 206 | 2 | DOID:687 (is_marker_for) | |
| Disease | Yu-Zhi constitution type | 4.80e-03 | 15 | 206 | 2 | EFO_0007638 | |
| Disease | S-warfarin measurement | 4.82e-03 | 97 | 206 | 4 | EFO_0803323 | |
| Disease | calcium measurement | MAP1A WDR81 ZCCHC2 KCNJ5 MYO18A ZFPM2 THBS3 PALM3 PRKAR2B ZFHX3 ABCC12 | 4.85e-03 | 628 | 206 | 11 | EFO_0004838 |
| Disease | hearing impairment | 5.00e-03 | 98 | 206 | 4 | C1384666 | |
| Disease | Schizoaffective disorder-bipolar type | 5.46e-03 | 16 | 206 | 2 | EFO_0009965 | |
| Disease | FEV/FEC ratio | BNC2 MYH9 DIPK1A DST CFDP1 MTCL1 ARAP1 COL6A3 DSPP CNKSR2 IL17RC REST TG THBS3 ZFHX3 CD276 HDLBP | 5.83e-03 | 1228 | 206 | 17 | EFO_0004713 |
| Disease | hypertension | 6.00e-03 | 307 | 206 | 7 | EFO_0000537 | |
| Disease | muscular dystrophy (is_implicated_in) | 6.16e-03 | 17 | 206 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | vital capacity | NCOA3 BNC2 INHBA CASZ1 RYR2 DST MTCL1 FKBP4 DYNC1I1 COL6A3 ZFAT DSPP ZCCHC8 CHD7 NCOR2 VRTN ZFHX3 | 6.21e-03 | 1236 | 206 | 17 | EFO_0004312 |
| Disease | Peripheral Nervous System Diseases | 6.40e-03 | 54 | 206 | 3 | C4721453 | |
| Disease | Metastatic melanoma | 6.40e-03 | 54 | 206 | 3 | C0278883 | |
| Disease | response to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy | 6.40e-03 | 54 | 206 | 3 | EFO_0000180, EFO_0003100, GO_0061479 | |
| Disease | triacylglycerol 52:2 measurement | 6.74e-03 | 55 | 206 | 3 | EFO_0010414 | |
| Disease | Gastric ulcer | 6.89e-03 | 18 | 206 | 2 | C0038358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DDLDGGTEEQGEQDF | 416 | Q9Y6N9 | |
| DSEGEDIEKESEGQA | 871 | Q15361 | |
| GEEDGKDTREEDGAD | 286 | Q86X53 | |
| EDAGDNDDTEGAIGV | 426 | Q9H0S4 | |
| GGQKEIEFGTSLDEE | 111 | P11171 | |
| AKKAEQGSEEEGEGE | 221 | Q8NE71 | |
| QAGKGDGEAEVEAEA | 206 | Q6ZW13 | |
| LDGEKGRDSGEEAHD | 391 | Q96G01 | |
| EEEDDKDAVGGGDLE | 281 | O95196 | |
| KDAVGGGDLEDENEL | 286 | O95196 | |
| EGDDNLGGEDKKETP | 556 | O43823 | |
| DAGSDEGILLDDIDG | 981 | Q6ZN30 | |
| EGILLDDIDGASDSG | 986 | Q6ZN30 | |
| KDGGALEEKDSDGAA | 141 | Q86V15 | |
| KGLAEVQQDGEAEEG | 581 | Q02952 | |
| ELDGGSVKETAAEEE | 6 | Q7Z5W3 | |
| EDKDADSLDEGLDGD | 636 | Q86TY3 | |
| AGGLDTEVALDEGKQ | 1446 | Q96L96 | |
| ETGDEEGLKEGDGEE | 406 | Q9ULD4 | |
| AEEEDEKGTAGGLLS | 451 | Q8NFM4 | |
| DDEDEEAGNGKDSSN | 261 | Q9NZW4 | |
| DTDLEAGLEEEAVGG | 161 | Q8NAV2 | |
| NEGDDVDKDLAGQDA | 161 | P27216 | |
| ASDAIKGEGLQEGVD | 161 | Q9H0F7 | |
| AGAEDQDGEGEGSKT | 501 | Q5ZPR3 | |
| DADGDGDFDVDDAKV | 91 | Q12797 | |
| KDGADEAESNDGKVL | 941 | Q6W2J9 | |
| GKVNEASGDGDGEDA | 66 | Q96C86 | |
| AQGEELDSLDGGDEI | 2976 | Q9P2D1 | |
| AVEKGSRVDGEDEEG | 321 | Q9ULX6 | |
| EKEQEEAEGGALDEG | 556 | Q9ULX6 | |
| ENKFVDEEDGGDGQA | 21 | O15511 | |
| DVQGEGLDEDAEQGD | 671 | Q6UXK2 | |
| LDTGEEAEEVGLKGE | 186 | P08476 | |
| EGGAGADEEKEQSHR | 276 | P08476 | |
| EARAGGDEDGEELEK | 806 | Q96L93 | |
| DLTEEGALAGQEKEE | 116 | Q9NX57 | |
| GKVGEDEDGSDEEVV | 2891 | P49792 | |
| SGQESEEEGAGEDLE | 176 | Q9Y4C8 | |
| NKSIDGTADDEDEGV | 626 | Q9NTI5 | |
| EDGKKGGDTDEDSEA | 71 | Q9ULW6 | |
| ASAGKAEDEGEGGRE | 41 | Q9BTK6 | |
| NKSIEGTADDEEEGV | 636 | Q29RF7 | |
| KDDNFGEGNDGGILD | 216 | O60216 | |
| NKGGEERKAEGGEED | 216 | P78412 | |
| DAESDAGKKESDGEE | 746 | Q9Y4B5 | |
| RLDEKVEEEGAGEGA | 356 | Q92806 | |
| GEETLEAEKRGGEES | 511 | A6NDB9 | |
| EEEGEEEEGGGNVEK | 1366 | Q8WYB5 | |
| AEAEQNEEDEPKGLG | 396 | P48544 | |
| CSADEVDEAEGGDKN | 921 | Q9Y618 | |
| DSEEGEGLEESADIK | 86 | Q13127 | |
| KEEKEEAEADDGGQG | 4831 | Q9NU22 | |
| EAEADDGGQGEDKIN | 4836 | Q9NU22 | |
| DKNGGEDTDNEEGEE | 4891 | Q9NU22 | |
| KDKEADEEGGENGPA | 4986 | Q9NU22 | |
| EEQGSKDRGLDSGAE | 601 | P78559 | |
| EDEDKEAINGSGNAE | 241 | Q5TCQ9 | |
| EQLDGGDTSSDEDKE | 696 | O60524 | |
| DENEAEGKGDNEGED | 796 | O60721 | |
| EGKGDNEGEDEGEIH | 801 | O60721 | |
| AKNDEKGVEDGGGSD | 841 | O60721 | |
| EEEEQKEGGDGAAGD | 36 | Q13442 | |
| KNLDEEGFESGDCGD | 486 | P51654 | |
| DQREDVAEDTKDGGG | 831 | Q9P107 | |
| FQEGDGKSAIGEEDE | 3811 | Q03001 | |
| ESDEEGSQEKGGDDS | 221 | Q9ULR0 | |
| KGDDEGIQETAESDG | 66 | Q8WW38 | |
| SGRELEEKDGDVQAG | 256 | O14576 | |
| DGKKEDEDPQDGGSL | 356 | Q9UKJ3 | |
| EDSEKEDDEGGGDQA | 351 | Q06265 | |
| EDDEGGGDQAIILDG | 356 | Q06265 | |
| LEILAKQAGEDGDDE | 916 | O95373 | |
| ELSGEDIKEFSEDNG | 356 | Q9UHC1 | |
| AEINGEVDDDDAGGE | 1356 | Q92614 | |
| EEKGLAAEDSGGDSK | 196 | P41227 | |
| ETDDGVVGKSSDGED | 276 | Q16649 | |
| DGAGNLDEEQDSEGE | 446 | O15117 | |
| EDGKEDEGGNEEEAG | 236 | P82970 | |
| PEAAEGDGDKKGNAE | 116 | P51858 | |
| GDGDKKGNAEGSSDE | 121 | P51858 | |
| LGKVESEQEELGSGE | 1256 | P48681 | |
| GVEDGEEGDLKTSLA | 376 | O75164 | |
| AKTGAGEVNGDVGDE | 271 | O60662 | |
| EDAGSEDELEEGGQL | 36 | P23443 | |
| LDTEGLGDVEKGDNQ | 96 | P32455 | |
| LDTEGLGDIEKGDNE | 96 | P32456 | |
| DNDGDGKIGAEEFQE | 91 | P0CE71 | |
| DGSDEEVDGKADGAE | 1941 | P35579 | |
| ADEGAADEEGEENGL | 311 | Q8N8V4 | |
| GDNDGAEDEDIRDSG | 196 | Q8N2Q7 | |
| GKGGDDKDDDEDDSG | 96 | Q13316 | |
| SSEEEGDRVEEDGKG | 121 | Q9Y3E1 | |
| DKEAEALQGAGTDGD | 36 | Q9H5V7 | |
| GDEKELESSEEGGSA | 11 | Q9HAS0 | |
| ASQKEGSDGDNEDDE | 226 | O94880 | |
| AEEKLAGEELAGEEA | 571 | Q7Z4V5 | |
| AGKALGGEDSENEEE | 766 | Q9BQG0 | |
| GGEDSENEEELGDEA | 771 | Q9BQG0 | |
| DLSGGLGGQEEEEEQ | 136 | Q9C086 | |
| GSGDDALDGDDDLVI | 226 | Q8NBZ0 | |
| ELGAEVGDEAGDKKS | 796 | A8MVW0 | |
| DGGEFEEGASENNAK | 436 | O43719 | |
| DNDGDGKIGAEEFQE | 91 | P0CE72 | |
| ALGGAADVEDTKEGE | 1011 | Q01970 | |
| NDGDEDEDIRDSGAK | 186 | Q9NZ94 | |
| DDAAEQEKGIGSEDA | 91 | Q9UEE9 | |
| EDDDSGDGMDVAGLD | 611 | Q9Y2F5 | |
| MDEEEDGAGAEESGQ | 1 | O43497 | |
| GDDADDEGNLSKGER | 1221 | O43497 | |
| KAEEGAQDDEGLLDN | 281 | Q9Y6A2 | |
| DGGQAEGAEDELEVR | 61 | Q9UBU3 | |
| EDDGVADESVKGLES | 431 | Q8IW35 | |
| ATEGLGDDALGKGQE | 861 | P53621 | |
| DGASVGEEEEEGKEE | 831 | Q8NHY3 | |
| GGKDADGSLAKEERE | 1211 | Q4ZHG4 | |
| NRLSEGDEGESDKGF | 781 | Q9P278 | |
| GDEGESDKGFAEDRG | 786 | Q9P278 | |
| EEFDKLQEGLDSSGD | 886 | Q9P0X4 | |
| EKDDGQKGEEAVGST | 36 | Q4G0X9 | |
| GVEDADEGALKEIAS | 176 | P12111 | |
| KANDGEGGDEEAGTE | 146 | Q9H3Q1 | |
| GDEDETFKDGITNGA | 311 | O75976 | |
| IGGDEDDKNIGSDED | 66 | P07766 | |
| SGINDEDDVENLGKE | 391 | Q8IY82 | |
| DDFLGKETGQQIGDE | 211 | Q9GZT9 | |
| DRGEEDADGSKTQDL | 746 | Q04637 | |
| DGETQDDGVDLKSET | 1231 | Q99698 | |
| GFDGADGEKAQQLDV | 246 | Q96A59 | |
| KELSNLTEEEGGEGG | 11 | Q8N6U8 | |
| KDGEHVIDQGDDGDN | 176 | P31323 | |
| DDEGGGEEDTQAFDI | 661 | P55289 | |
| SAIKDAEEDDDTGGI | 706 | Q13206 | |
| EFKGEDLTEEEDGGI | 136 | Q02790 | |
| LLSGEGKGSTDDEAE | 1166 | O95180 | |
| LFKDEATDGGGDNKE | 1226 | Q14839 | |
| EAEVATEKEGEDGDQ | 166 | P18858 | |
| TVADGDKDGQVSLGE | 176 | Q5T7M9 | |
| VEAGEGEAEKEEAGA | 371 | Q6NYC8 | |
| DEAIEDDIKEADGGG | 1031 | Q96T23 | |
| DDAKLQGAGEEEAKG | 1871 | Q92736 | |
| GEEDTEDQGLTGDEA | 156 | O75923 | |
| EGLKFVEDSAESEDG | 386 | Q8NFZ4 | |
| EEGEKAATAEGEGVQ | 351 | Q96A83 | |
| ALTEGAKEEGGEEVA | 896 | Q9Y2J2 | |
| DVVGEGDDGLEEKDS | 26 | Q9UJU5 | |
| EDEEKFGGAADSGVE | 171 | Q8NAC3 | |
| AGGEELDEGVAKDNA | 691 | Q32MZ4 | |
| AGEVSKERESGDGEA | 831 | Q7Z6I6 | |
| KGRLSGDEGSEDGDD | 71 | P35680 | |
| DEDFAKDENITKGGE | 301 | A1Z1Q3 | |
| EGAEDSKGNGIEEQE | 796 | Q92834 | |
| EEQSSDAGLFKEEGG | 376 | P78332 | |
| EDDGDQVEDDGETAK | 976 | Q6WKZ4 | |
| ANGKGVKIEFDEDDG | 451 | Q6ZMZ0 | |
| AEEEDGEAGAEDKRS | 406 | O15240 | |
| AEEAGGEEGKREAEA | 51 | Q5TG53 | |
| TQEGEDGDGDLADEE | 1686 | P21675 | |
| DGDGDLADEEEGTVQ | 1691 | P21675 | |
| EEGSGDLDNLDAILG | 791 | Q9Y6Q9 | |
| EQDGNDELKDSEEFG | 116 | Q9NWH9 | |
| AQDGEEEENEKDIAG | 186 | Q9NWH9 | |
| EEENEKDIAGSGDGT | 191 | Q9NWH9 | |
| TEAATGLEGEEKDGI | 601 | Q8IY81 | |
| GLEGEEKDGISDSDS | 606 | Q8IY81 | |
| DADGEAEEEGESEKG | 126 | A6NIN4 | |
| DLNSKENLDADEGDG | 386 | Q9P2F8 | |
| ENLDADEGDGKSNDL | 391 | Q9P2F8 | |
| DQDGGGDDKREEGSL | 386 | Q8TBK2 | |
| DGIPGDEQAENKEDD | 156 | Q13621 | |
| KNLVGALDEGDGESA | 391 | Q53LP3 | |
| GDEDAEEAAAEKRGL | 456 | Q14160 | |
| GNEKDEGKESETGSE | 741 | Q96J65 | |
| LQEKEGGEAEESATD | 271 | Q9NWQ8 | |
| KGGTVADLDEQDEET | 401 | Q92922 | |
| EEEGVEDNGLEENSG | 96 | Q15424 | |
| LLSEGEELSGDDQGD | 266 | Q96P48 | |
| LLDDGAGADVIKNDG | 656 | Q9UQC9 | |
| VTTQEGDGKGDKDGE | 106 | Q16280 | |
| SEGGEEEGKENEDKQ | 706 | Q9NQW8 | |
| ASKEGGAGAVDEDDF | 56 | O75122 | |
| EGEAAGENIGEKSES | 886 | Q8WXI2 | |
| RGEDGDGEQDAEKDG | 221 | Q9C0B9 | |
| CKDLDEDANGITDEG | 296 | Q5QJE6 | |
| EKLQEEGGGSDEEET | 41 | Q13610 | |
| DEKGNDSDGEGESDD | 96 | O75351 | |
| EIGTEDEKGDREGAF | 411 | Q6B0B8 | |
| GLQTGLDGSEEEEKG | 51 | P13682 | |
| EEEVLGSGRAEKNGD | 71 | Q96PE6 | |
| KAEEGGETEAQKEGS | 171 | P55822 | |
| DSDLNKDEFGELEGT | 526 | Q9ULJ3 | |
| FKDDDGDEEDENGVG | 31 | Q6NZY4 | |
| GDEEDENGVGDAELR | 36 | Q6NZY4 | |
| NLGEEEGEAGNESDL | 141 | Q9P243 | |
| KFSGEEGEIEDDESG | 926 | Q9Y2W1 | |
| GSGREEDDELLGNDD | 46 | Q9Y548 | |
| EESADEQKGSEAEGL | 206 | Q9Y5A6 | |
| EEKLDTGTEEEFGGL | 1611 | Q8IZQ1 | |
| EEALKEQEEGTGDSS | 151 | P62256 | |
| DADENEFLGNIDGGD | 366 | Q9UNN4 | |
| GQGKGDDVIVIDSDD | 1936 | P12270 | |
| EAEQEKEEDSLGAGT | 726 | Q9P2H5 | |
| LLEEEGAGAGAAQEE | 1481 | Q9C0C2 | |
| GLGADGQEHKEDTFD | 1051 | Q8IX01 | |
| KGDLGKDSEESEEDG | 876 | Q9H5I5 | |
| SDISDAGEDGEGKVD | 846 | O15014 | |
| QDGAISTDAEGKEEE | 1141 | P29144 | |
| DGGQEDGSEADRGKL | 16 | Q9Y5S1 | |
| DSLEEGQVDDAGKAL | 391 | O94876 | |
| NDEKAEEAGEGRGDS | 106 | Q71RG4 | |
| DQCDDDADGDGIKNV | 501 | P49746 | |
| LREEDLEDGSKGGGD | 501 | Q9NRE2 | |
| EGEDGEDTAKICQAD | 161 | O15213 | |
| DIEGKENSLAEDKDG | 991 | Q4KWH8 | |
| KDLEEQDGHDLGAAG | 436 | Q9H9P5 | |
| QGPGDKGDVFDEEAD | 11 | Q9NRH1 | |
| GDIVGLDLGEEAEKE | 21 | A6NLP5 | |
| KDGGNGEVVTLDEEA | 3056 | Q7Z7G8 | |
| LEELEEGQKGVGDGT | 16 | Q15819 | |
| DDEDGGEAEKEGTAD | 36 | Q5T619 | |
| ENGDEAGEGREAKDC | 926 | Q00341 | |
| GGDQPKEEEGDDFLD | 71 | Q96HH4 | |
| KSEAEEGAGNATGED | 476 | Q9H8Y1 | |
| AGASEKAEDANKEEG | 91 | Q9H489 | |
| GAKGGQSAESEEEEL | 2731 | P01266 | |
| EDEEEEKREDGGAGS | 121 | Q9H091 | |
| ESKDLAGAAEEEESG | 1021 | Q562E7 | |
| GAGEGAEEAAKDLAD | 31 | O75962 | |
| GEDRDTASEKELNGD | 651 | Q15061 | |
| SEGKDSGAAEGEKQE | 431 | Q15911 | |
| SGAAEGEKQEVGDGD | 436 | Q15911 | |
| EEGGLQKEGLAVAEE | 291 | B0I1T2 | |
| EGAKSDQAEEGGSEK | 541 | P07197 | |
| GGSEKEGSSEKEEGE | 551 | P07197 |